|
Monday, 17 September 2018
09:00
16:30
Fellowships Meeting
by invitation only
Auditorium 2
09:30
12:30
ESSENCE Meeting
by invitation only
Sala / Room 4
12:00
16:00
High Level Meeting
by invitation only
Auditorium 3
15:00
19:00
Registration
Registration Desk
17:00
18:30
Plenary Session I
Plenary Session
Auditorium 1
17:00
Welcome address and opening of the Ninth EDCTP Forum
Welcome Address
Auditorium 1
Mark Palmer - Chair of EDCTP Board and General Assembly
Pedro Norton - Fundação Calouste Gulbenkian
Cornelius Schmaltz - Head of Unit RTD E3, Fighting Infectious Diseases and Advancing Public Health, European Commission
Professor Helena Pereira, Vice-President, Foundation for Science and Technology (FCT)
Minister Manuel Heitor, Minister for Science, Technology and Higher Education
17:15
Growing up HIV-positive in Africa: challenges facing the continent
Keynote Address
Auditorium 1
Cissy Kityo Mutuluza - Executive Director, Joint Clinical Research Centre
18:30
19:00
EDCTP Prizes Ceremony
Ceremony
Auditorium 1
19:00
21:00
Welcome Reception
Social Programme
Foyer 1
Tuesday, 18 September 2018
08:00
18:00
Registration
Registration Desk
09:00
10:00
Plenary Session II
Plenary Session
Auditorium 1
09:00
10:00
Tackling public health emergencies in Africa
Keynote Address
Auditorium 1
John Nkengasong - Africa Centres for Disease Control and Prevention
10:00
10:30
Coffee Break
Break
Foyer 1
10:30
12:30
Clinical research for epidemic-prone infectious diseases in sub-Saharan Africa
Scientific Symposium
Auditorium 1
Organized by University of Oxford (UK)
Despite recent impressive gains in reducing the burden of endemic infectious diseases, sub-Saharan Africa remains highly vulnerable to a range of epidemic prone infections. This includes high-profile diseases such as the viral haemorrhagic fevers and plague, but also more common-place infections such as cholera and influenza. In recognition of this vulnerability to outbreaks and their health and economic consequences, EDCTP launched a call to establish networks for research and clinical management of patients in poverty-related disease epidemics in sub-Saharan Africa.
The African coaLition for Epidemic Research, Response and Training (ALERRT) and the Pan-African Network For Rapid Research, Response, Relief And Preparedness For Infectious Diseases Epidemics (PANDORA-ID-NET) are the two consortia funded through this call. The over-arching aim of these consortia is to strengthen capacities and systems for a rapid and effective research response to infectious diseases with epidemic potential and to conduct research that will generate and disseminate the evidence needed by clinicians and public health authorities to make the best possible decisions for patients and populations. This symposium will present the ALERRT and PANDORA-ID-NET consortium and a sample of the research they are conducting on epidemic-prone infectious diseases in sub-Saharan Africa.
The African coaLition for Epidemic Research, Response and Training (ALERRT)
Scientific Symposium
Auditorium 1
Pan-African Network for Rapid Research, Response, Relief and Preparedness for Infectious Diseases Epidemics (PANDORA-ID-NET)
Scientific Symposium
Auditorium 1
Lassa fever outbreak, Nigeria, 2017-2018
Scientific Symposium
Auditorium 1
Facilitating ethical review of research during public health emergencies
Scientific Symposium
Auditorium 1
Plague outbreak, Madagascar, 2017-2018
Scientific Symposium
Auditorium 1
Facilitating research capacity development to strengthen preparedness for epidemic outbreaks
Scientific Symposium
Auditorium 1
Engaging ‘communities’ in health research on (re)emerging epidemics in Africa
Scientific Symposium
Auditorium 1
12:15
Ensuring ALERRT is a trusted partner at national, regional and global levels
Scientific Symposium
Auditorium 1
10:30
12:30
Data-sharing for global research good: Case studies and tools from malaria, Ebola and visceral leishmaniasis research programmes
Scientific Symposium
Auditorium 2
Organized by Infectious Diseases Data Observatory (IDDO, Senegal).
Many funders of biomedical research encourage grant-holders to share their primary data for potential reuse, and an increasing number of journals require that the data supporting manuscript outcomes be made available upon publication. However, it is not always clear how to ensure that the data made available are usable and useful to the research community, contribute to evidence that improves patient outcomes, and are shared in an equitable manner.
Pioneering approaches to establish data platforms for poverty-related diseases and emerging infections have delivered a data-sharing framework following FREE FAIRER principles (Findable, Rapidly available, Ethical, Equitable, Forever, Accessible, Interoperable, Reliable, Economically viable, and Reusable).
This symposium will provide suggestions on how to optimise the potential for data reuse, from the point of data collection to the use of data for generating reliable evidence. The panel from will showcase approaches for the collection, organisation, governance and reuse of data, using examples from malaria, visceral leishmaniasis and Ebola. Tools and resources will be introduced that are available to the EDCTP research community, including a multi-disciplinary data-sharing toolkit available through EDCTP and The Global Health Network.
Generating reliable evidence from IPD meta-analyses: examples from antimalarial drug resistance research
Scientific Symposium
Auditorium 2
11:00
Establishing equitable governance and partnership for the Ebola data platform
Scientific Symposium
Auditorium 2
11:30
Developing a data-sharing platform for visceral leishmaniasis research
Scientific Symposium
Auditorium 2
12:00
The malaria clinical trials toolkit: a practical overview for researchers
Scientific Symposium
Auditorium 2
10:30
12:30
Synergies between diagnostics and treatment studies in human African trypanosomiasis: examples of collaboration from the DiTECT-HAT and HAT-r-ACC projects
Scientific Symposium
Auditorium 3
Organized by Drugs for Neglected Diseases Initiative (DNDi, Switzerland)
Control of human African trypanosomiasis (HAT) relies heavily on accurate diagnosis and subsequent treatment of infected patients. The work of developing new rapid diagnostic tests and treatments over the last decade may simplify patient management considerably in the near future. This symposium will demonstrate how advances in HAT diagnostics and drugs influence each other, and how epidemiologic understanding is a basic foundation of planning for research and HAT elimination efforts. Examples of synergies between HAT diagnostics and treatment studies to improve clinical trial inclusion and train health staff, and by sharing patients and data between trials will be presented. Collaboration between these fields is important, as both diagnostics research and clinical trials for new drugs are essential for policy change to simplify treatment, improve access and maintain disease elimination.
Partnership in research for HAT
Scientific Symposium
Auditorium 3
The value of the HAT Atlas in planning for disease elimination and research
Scientific Symposium
Auditorium 3
The influence of treatment on diagnosis and staging of HAT, from melarsoprol to acoziborole
Scientific Symposium
Auditorium 3
11:15
Clinical signs and symptoms of HAT revisited: their use for improvement of predictive value of laboratory diagnosis
Scientific Symposium
Auditorium 3
11:30
Challenges of clinical research for HAT on the path to elimination
Scientific Symposium
Auditorium 3
11:45
Future perspectives on HAT diagnosis and post-treatment follow-up
Scientific Symposium
Auditorium 3
10:30
12:30
Optimizing the impact of research partnerships for all partners – the Research Fairness Initiative (RFI)
Scientific Symposium
Sala / Room 4
Organized by Council on Health Research for Development (COHRED, Switzerland)
Research happens through partnerships. Without partnerships, (substantive) research and innovation is not possible. Achieving research excellence and relevance is therefore the first reason why this Symposium focuses on the quality and fairness of partnerships.
The second reason is that partnerships are essential to building sustainable research and innovation systems in Africa. Few countries in Africa are investing adequately in their own science environment. Externally funded research and innovation partnerships can achieve what governments are not funding – provided such partnerships are fair.
The last reason is that calls for research proposals typically want to achieve two goals – a scientific goal (knowledge, product or service) and a partnership goal (institutional and national research capacity). For the scientific objectives there is an extensive metric and many accepted criteria to measure performance. For the partnership objective there is (virtually) none and certainly not one that is widely accepted.
These are the core issues that the Research Fairness Initiative (RFI) addresses head on, and where it can add value to research institutions in ‘north’ and ‘south’, to funders, to non-profits, to business, to all stakeholders in research and innovation for health, equity and development.
There is no doubt that Africa needs international partnerships to develop its science base further - and there is also no doubt that many of the current partnerships are far from optimal - for example, in terms of sharing intellectual property, authorship, data ownership, decision making, access to funding, and its fair share of spin-off business opportunities.
In this Symposium, RFI experts, RFI implementers and the audience will share their views on how the RFI is adding value to the research partnerships they are involved in – what can be improved – and why you should consider encouraging your own home institution to become a RFI Reporting Organisation as well.
Application of the RFI in INSERM and AVIESAN Sud
Scientific Symposium
Sala / Room 4
Added value of the RFI to IRESSEF – experiences in preparing our first RFI report
Scientific Symposium
Sala / Room 4
11:00
The WHO/TDR RFI Report: benefits and challenges from a funder’s perspective
Scientific Symposium
Sala / Room 4
Benefits of the RFI to national governments: analysis of the RFI Reports of three key Senegalese institutions
Scientific Symposium
Sala / Room 4
The RFI – implementation at the IHTM, and its adoption in the Community of Portuguese Language Countries (CPLP)
Scientific Symposium
Sala / Room 4
12:30
14:00
Lunch
Break
Foyer 1
12:30
13:15
E-poster Presentation
E-poster Presentation
Sala / Room 1
Monitor 1: Ethics, regulatory & pharmacovigilance
E-poster Presentation
Sala / Room 1
Ditai, James
PO - (8194) - OPTIMIZED INFORMED CONSENT FOR PARTICIPANTS IN A RANDOMISED CONTROLLED TRIAL IN RURAL UGANDA: A COMPARATIVE PROSPECTIVE COHORT STUDY
Ditai, James (Uganda)1; Kanyago, Jesca (Uganda)1; Nambozo, Rachael (Uganda)1; Kanyago, Nathan (Uganda)1; Abeso, Julian (Uganda)1; Olupot, Peter (Uganda)2; Carrol, Enitan (United Kingdom)3; Gladstone, Melissa (United Kingdom)3; Weeks, Andrew (United Kingdom)3; Faragher, Brian (United Kingdom)4; Medina-Lara, Antonietta (United Kingdom)3; Storr, Julie (United Kingdom)5
1 - Sanyu Africa Research Institute; 2 - Busitema University Faculty of Health Sciences; 3 - University of Liverpool; 4 - Liverpool School of Tropical Medicine; 5 - World Health Organization
Kombe, Francis
PO - (8254) - LESSONS LEARNT FROM SCALING UP OF AN ONLINE SYSTEM FOR REVIEW AND MANAGEMENT OF PROTOCOLS IN SUB-SAHARAN AFRICA
Ngongo, Prince Bahati (Kenya)1; Kombe, Francis (Kenya)2; Kamali, Anatoli (Kenya)1; Ijsselmuiden, Carel (Switzerland)2
1 - International AIDS Vaccine Initiative; 2 - Council on Health Research and Development
Adu-Boahen, Yvonne
PO - (8300) - REGIONAL CENTER FOR REGULATORY EXCELLENCE CLINICAL TRIALS TRAINING 2017
Darko, Delese (Ghana)1; Adu-Boahen, Yvonne (Ghana)1
1 - Food and Drugs Authority
Ndorbor, Theophilus
PO - (8381) - REGULATING CLINICAL TRIAL DURING AN EBOLA EMERGENCY; THE LIBERIAN EXPERIENCE
Ndorbor, Theophilus (Liberia)1; Sumo, David (Liberia)1; Kercula, Juwe D. (Liberia)1; Hallie, Ezekiel F. (Liberia)2
1 - Liberia Medicines and Health Products Regulatory Aurthority; 2 - School of Pharmacy, University of Liberia
Kajungu, Dan
PO - (8438) - THE KNOWLEDGE, ATTITUDE AND PERCEPTIONS ON ADVERSE DRUG EVENTS REPORTING AMONG PATIENTS AND HEALTHCARE PROVIDERS IN RURAL UGANDA
Ndagije, Helen (Uganda)2; Nambasa, Victoria (Uganda)2; Kajungu, Dan (Uganda)1
1 - Makerere University Centre for Health and Population Research-Iganga Mayuge HDSS, Uganda; 2 - National Drug Authority, Uganda
George, Alexander E.
PO - (8475) - ENHANCING THE CAPACITY OF THE LIBERIA MEDICINES AND HEALTH PRODUCTS REGULATORY AUTHORITY IN POST-MARKETING SURVEILLANCE OF IN VITRO DIAGNOSTICS
George, Alexander E. (Liberia)1; Somwarbi, Joseph N. (Liberia)1; Sumo, David (Liberia)1; Martínez Pérez, Guillermo (Spain)2; Mayor, Alfredo (Spain)2
1 - Liberia Medicines and Health Products Regulatory Authority; 2 - ISGlobal, Hospital Clínic - Universitat de Barcelona
Kombe, Francis
PO - (8746) - IMPACT OF EXPANDED USE OF AN ONLINE ETHICS REVIEW SYSTEM IN AFRICA: A PARTNERSHIP BETWEEN IAVI, COHRED, EDCTP WITH NATIONAL REGULATORY AGENCIES
Kombe, Francis (Kenya)1
1 - Council on Health Research for Development (COHRED, Kenya)
Patrão Neves, Maria Do Céu
PO - (8536) - BIOMEDICAL ETHICS AND REGULATORY CAPACITY BUILDING PARTNERSHIP FOR PORTUGUESE SPEAKING AFRICAN COUNTRIES (BERC-LUSO)
Patrão Neves, Maria Do Céu (Portugal)1; Ribeiro, Maria Alexandra (Portugal)2; Carvalho, Ana Sofia (Portugal)3; Araújo, Joana (Portugal)3; Martins, Sofia Oliveira (Portugal)4; Martins, Ana Paula (Portugal)1; Mota Filipe, Helder (Portugal)1; Rhodes Baião, Luís (Portugal)1; Batista, Jorge (Portugal)1; Afonso, Joana (Angola)5; Mangueira, Katiza (Angola)6; Reis, Carla Djamila (Cape Verde)7; Na Banga, Cunhate (Guinea-Bissau)8; Sitoie, Tânia (Mozambique)9
1 - Ordem dos Farmacêuticos; 2 - Comissão de Ética para a Investigação Clínica; 3 - Universidade Católica Portuguesa - Instituto de Bioética; 4 - Infarmed - Autoridade Nacional do Medicamento e Produtos de Saúde I.P.; 5 - Instituto Nacional de Saúde Pública do Ministério da Saúde de Angola; 6 - Direção Nacional de Medicamentos e Equipamentos do Ministério da Saúde de Angola; 7 - Agência de Regulação e Supervisão dos Produtos Farmacêuticos e Alimentares; 8 - Comité Nacional de Ética em Pesquisa em Saúde do Instituto Nacional de Saúde Pública do Ministério da Saúde Pública da Guiné Bissau; 9 - Departamento Farmacêutico do Ministério da Saúde de Moçambique
Monitor 2: Diarrhoeal diseases and NIDs
E-poster Presentation
Sala / Room 1
De Souza, Dziedzom
PO - (8239) - BASELINE ASSESSMENT OF LYMPHATIC FILARIASIS IN 18 COMMUNITIES IN WESTERN GHANA, BEFORE THE IMPLEMENTATION OF A TWICE-YEARLY TREATMENT
De Souza, Dziedzom (Ghana)1; Ahorlu, Collins (Ghana)1; Otchere, Joseph (Ghana)1; Mensah, Sedzro (Ghana)1; Adu-Amankwah, Sudan (Ghana)1; Boakye, Daniel (Ghana)1
1 - Noguchi Memorial Institute for Medical Research, University of Ghana
Ogbuagu, Chukwuanugo
PO - (8369) - BURULI ULCER: PATTERN OF PRESENTATION IN A NIGERIAN HOSPITAL
Ogbuagu, Chukwuanugo (Nigeria)1; Enweani, Ifeoma (Nigeria)2; Maurice, Agu (Nigeria)3; Ogbuagu, Ekenechukwu (Nigeria)1; Emelumadu, Obiageli (Nigeria)1
1 - Nnamdi Azikiwe University Teaching Hospital Nnewi Nigeria; 2 - Nnamdi Azikiwe University Awka Nigeria; 3 - Nnewi Diocesan Hospital Nnewi Nigeria
Veletzky, Luzia
PO - (8382) - CLINICAL AND LABORATORY ASSESSMENT OF LOA LOA INFECTIONS IN GABON
Veletzky, Luzia (Germany)1; Zoleko-Manego, Rella (Gabon)2; Stelzl, Daniel (Gabon)2; Hergeth, Jennifer (Gabon)2; Dimessa Mbaginga, Lia Betty (Gabon)2; Budke, Christine (United States of America)3; Mischlinger, Johannes (Germany)1; Mombo-Ngoma, Ghyslain (Germany)2; Adegnika, Ayôla Akim (Gabon)2; Metzger, Wolfram (Germany)4; Lagler, Heimo (Austria)5; Kremsner, Peter G (Austria)4; Mordmüller, Benjamin (Germany)4; Ramharter, Michael (Germany)1
1 - Bernhard-Nocht-Institute for Tropical Medicine and University Medical Center Hamburg-Eppendorf; 2 - Centre de Recherches Médicales de Lambaréné; 3 - Texas A&M University; 4 - Institute for Tropical Medicine University of Tuebingen; 5 - Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna
Adetunde, Oluwasegun
PO - (8430) - A GEOSPATIAL APPROACH TO PREDICTING DIARRHEA PREVALENCE IN NIGERIA.
Adetunde, Oluwasegun (Nigeria)1
1 - Department of Geography and Environmental Management, University of Ilorin, Nigeria
Manouana, Gédéon Prince
PO - (8444) - CHARACTERISATION OF PATHOGENS CAUSING DIARRHOEA IN CHILDREN UNDER FIVE IN LAMBARÉNÉ, GABON
Manouana, Gédéon Prince (Gabon)1,2; Bingoulou Matsougou, Gedeon (Gabon)1,3; Byrne, Natalie (Germany)4; Hofmann, Philipp (Germany)5; Mbong Ngwese, Mirabeau (Gabon)1; Nguema Moure, Pau Alvyn (Gabon)1; Zinsou, Jeannot (Gabon)1; Agobe, Jean-Claude (Gabon)1; Adegbite, Bayode Romeo (Gabon)1; Edoa, Jean Ronald (Gabon)1; Honkpehedji, Yabo Josiane (Gabon)1; Mccall, Matthew Benjamin Bransby (Gabon)1; Alabi, Abraham Sunday (Gabon)1; Eibach, Daniel (Germany)6,7; Kremsner, Peter Gottfried (Germany)1,2; Borrmann, Steffen (Germany)2; Adegnika, Ayola Akim (Gabon)1,2
1 - Centre de Recherches Médicales de Lambaréné, BP : 242, Lambaréné, Gabon; 2 - Institut für Tropenmedizin, Universität Tübingen, Wilhelmstraβe 27 D-72074 Tübingen, Germany; 3 - Faculté de médecine, Université des Sciences de la Santé, Libreville, Gabon; 4 - Faculty of Medicine, Universität Tübingen , Germany; 5 - Charité- Universitätmedizin Berlin, Germany; 6 - Bernhard Nocht Institute for Tropical Medicine; 7 - German Center for Infection Research, and Hamburg-Borstel-Lübeck, Germany
Dejon Agobé, Jean Claude
PO - (8449) - SCHISTOSOMA HAEMATOBIUM INFECTION INCREASES THE NUMBER OF MALARIA EPISODES IN CHILDREN LIVING IN RURAL AREAS AROUND LAMBARÉNÉ, GABON
Dejon Agobé, Jean Claude (Gabon)1; Edoa, Jean Ronald (Gabon)1; Honkpehedji, Yabo Josiane (Gabon)1; Zinsou, Jeannot Fréjus (Gabon)1; Adegbité, Bayodé Roméo (Gabon)1; Lell, Bertrand (Gabon)1; Grobusch, Martin Peter (Netherlands)2; Mordmüller, Benjamin (Germany)3; Adegnika, Ayola Akim (Gabon)1
1 - Centre de Recherches Médicales de Lambaréné (CERMEL); 2 - Academic Medical Center, University of Amsterdam; 3 - University of Tübingen
Mikounou Louya, Vivaldie Edwige
PO - (8524) - MOLECULAR CHARACTERIZATION OF THE NOROVIRUS STRAINS RESPONSIBLE FOR ACUTE DIARRHEA IN CHILDREN UNDER FIVE YEARS OLD HOSPITALIZED IN BRAZZAVILLE
Mikounou Louya, Vivaldie Edwige (Congo)1; Koukouikila-Koussounda, Félix (Congo)2; Vouvoungui, Christevy (Congo)2; Kobawila, Simon Charles (Congo)3; Ntoumi, Francine (Congo)4
1 - Congoles Foundation for the Medical Research; 2 - Congolese Foundation for the Medical Research; 3 - Faculty of Science and TUechnics, Marien Ngouabi University; 4 - Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Ndahura, Mandro
PO - (8576) - EFFECT OF IVERMECTIN TREATMENT ON THE FREQUENCY OF SEIZURES IN PERSONS WITH ONCHOCERCIASIS-ASSOCIATED EPILEPSY: PRELIMINARY RESULTS OF RANDOMIZED CLINICAL TRIAL
Ndahura, Mandro (Congo (the Democratic Republic of the))1; Mukendi, Deby (Congo (the Democratic Republic of the))2; Nyisi, Françoise (Congo (the Democratic Republic of the))3; Rossy, Deogracias (Congo (the Democratic Republic of the))4; Siewe, Joseph (Congo (the Democratic Republic of the))5; Abhafule, Germain (Congo (the Democratic Republic of the))3; Nakato, Swabra (Belgium)5; Suykerbuyk, Patrick (Belgium)6; Siewe, Joseph (Belgium)7; An, Hotterbeekx (Belgium)8; Colebunders, Robert (Belgium)8; Sonia, Menon (Belgium)8
1 - Ministry of Health of Ituri Province; 2 - University of Kinshasa; 3 - Centre de Recherche en Maladies Tropiclales de l'Ituri/Hopital de Rethy; 4 - Programme National de Maladies Tropicales Négligées/Ituri Sud; 5 - Global Health Institute, University of Antwerp, Belgium; 6 - Fondation Damien; 7 - Global Health Institute, University of Antwerp; 8 - UA/Faculteit GGW/ESOC/Global Health Institute
Monitor 3: Malaria
E-poster Presentation
Sala / Room 1
Christelle, Ngou Maffo
PO - (8290) - INFLUENCE OF THE SICKLE CELL TRAIT ON PLASMODIUM FALCIPARUM TRANSMISSION IN ASYMPTOMATIC CHILDREN
Christelle, Ngou Maffo (Cameroon)1; Antoine, Berry (France)3; Isabelle, Morlais (France)4; Lionnel Brice, Feufack Donfack (Cameroon)1; Albert, Bayibeki Ngano (Cameroon)1; Sandrine Eveline, Nsango (Cameroon)2; Elangwe Milo, Sarah-Matio (Cameroon)1; Lawrence, Ayong (Cameroon)1
1 - Malaria Unit, Centre Pasteur du Cameroun; 2 - Faculty of medecine University of Douala; 3 - Service de Parasitologie-Mycologie CHU Toulouse/Université Toulouse III; 4 - Equipe MIVEGEC-IRD de Montpellier
Adigbonon, Claudiane
PO - (8418) - NEW MALARIA EPIDEMIOLOGY IN COASTAL LAGOON OF BENIN : PLASMODIUM INFECTION IN ANOPHELES MELAS.
Adigbonon, Claudiane (Benin)1; Assogba, Benoît Sessinou (Senegal)2; Djogbenou, Luc Salako (Benin)3
1 - C. Adigbonon; 2 - B.S. Assogba; 3 - L.S. Djogbénou
Bonne, Ciza
PO - (8467) - IMPACT OF COMMUNITY CASE MANAGEMENT OF MALARIA(CCMM) AMONG CHILDREN UNDER FIVE YEARS: AN EVALUATIVE STUDY IN KABONGA
Bonne, Ciza (Burundi)1; Husseni, Kagozi (Burundi)2; Muhigirwa, Ciza Josephine (Burundi)3
1 - Health Healing Network Burundi(HHNB); 2 - Solidarity of nurses for promotion of maternal and children's health; 3 - Palliative care association of Burundi
Gampio Gueye, Nerly Shirère
PO - (8527) - GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND ASSOCIATION WITH UNCOMPLICATED MALARIA IN CONGOLESE CHILDREN CONSULTING IN A PEDIATRIC HOSPITAL IN BRAZZAVILLE
Gampio Gueye, Nerly Shirère (Congo)1; Thirumalaisamy P, Velavan (Germany)2; Vouvoungui, Christevy (Congo)1; Kobawila, Simon Charles (Congo)2; Nderu, David (Germany)2; Koukouikila-Koussounda, Felix (Congo)1; Ntoumi, Francine (Congo)1
1 - Congolese Foundation for Medical Research; 2 - Institute of Tropical Medicine Universitätsklinikum Tübingen
Zoleko-Manego, Rella
PO - (8563) - UNCOMMON HIGH AND SYMPTOMATIC PLASMODIUM FALCIPARUM INFECTIONS IN GABONESE ADULT
Zoleko-Manego, Rella (Gabon)1,2,3; Koehne, Eric (Gabon)1,2; Mombo-Ngoma, Ghylain (Gabon)1,2,3
1 - Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon; 2 - Institute of Tropical Medicine, University of Tuebingen and German Centre for Infectious Diseases (DZIF), Tuebingen, Germany; 3 - Bernhard Nocht Institute for Tropical Medicine, World Health Organization Collaborating Centre for Arbovirus and Hemorrhagic Fever Reference and Research, Hamburg, Germany
Lusingu, John
PO - (8575) - EVOLUTION OF MALARIA MORBIDITY IN TWO VILLAGES IN KOROGWE, TANZANIA
Lusingu, John (Tanzania)1; Minja, Daniel (Tanzania)1; Theander, Thor (Denmark)2
1 - National Institute for Medical Research; 2 - University of Copenhagen, Denmark
Traore, Karim
PO - (8594) - VALIDATION OF A VERBAL AUTOPSY QUESTIONNAIRE APPLIED TO A CASE-CONTROL STUDY OF CEREBRAL MALARIA IN BANDIAGARA AND BAMAKO, MALI.
Traore, Karim (Mali)1; Coulibaly, Drissa (Mali)1; Kone, Abdoulaye K (Mali)1; Thera, Ali (Mali)1; Guindo, Boureima (Mali)1; Tangara, Bourama M (Mali)1; Diawara, Aichatou A (Mali)1; Doumbo, Ogobara K (Mali)1; Thera, Mahamadou A (Mali)1
1 - MRTC/FMOS, University of Sciences, Techniques and Technologies of Bamako, Point G, BP 1805, Bamako, Mali
Hamid, Muzamil Mahdi Abdel
PO - (8609) - PREVALENCE AND RISK FACTORS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN TWO P. VIVAX MALARIA ENDEMIC AREAS IN SUDAN
Hamid, Muzamil Mahdi Abdel (Sudan)1; Albsheer, Musab (Sudan)1; Muneer, Mohamed (Sudan)1; Altinae, Lina (Sudan)1; Lover, Andrew A. (United States of America)2
1 - Institute of Endemic Diseases, University of Khartoum; 2 - 2. Institute for Global Health Sciences, University of California, San Francisco
12:30
13:15
E-poster Presentation
E-poster Presentation
Sala / Room 2
Monitor 1: Co-infections and co-morbidities
E-poster Presentation
Sala / Room 2
Shiluli, Clement
PO - (8182) - INVESTIGATING TREATMENT RESPONSE OF PATIENTS WITH CONFIRMED DRUG RESISTANT TUBERCULOSIS IN A HIV-1 ENDEMIC POPULATION IN WESTERN KENYA
Shiluli, Clement (Kenya)1; Ouma, Collins (Kenya)1; Khayumbi, Jeremiah (Kenya)2; Murithi, Wilfed (Kenya)2; Ochieng, Albert (Kenya)2; Musau, Susan (Kenya)3
1 - Department of Biomedical Sciences and Technology, Maseno University; 2 - Kenya Medical Research Institute, Centre for Global Health Research; 3 - Maryland Global Initiatives Corporation
Peko, Simon Marie
PO - (8261) - CYTOCHROME P450 (CYP2B6*6C.516G>T) VARIANTS IN CONGOLESE INDIVIDUALS WITH HIV AND TB MONO AND DUAL INFECTIONS.
Peko, Simon Marie (Congo)1
1 - Fondation Congolaise pour la Recherche Médicale (FCRM)
Bakarey, Adeleye Solomon
PO - (8275) - HEPATITIS B VIRUS IMMUNE ESCAPE MUTANTS AMONG APPARENTLY HEALTHY INHABITANTS IN IBADAN SOUTHWESTERN NIGERIA
Bakarey, Adeleye Solomon (Nigeria)1; Ifeorah, Ijeoma Maryjoy (Nigeria)2; Akere, Adegboyega (Nigeria)1
1 - College of Medicine, University of Ibadan, Ibadan, Nigeria; 2 - University of Nigeria, Nsukka, Nigeria
Anderson, Motswedi
PO - (8481) - HIGH HEPATITIS B VIRUS INCIDENCE AMONG HIV-1 INFECTED TREATMENT NAIVE ADULTS IN BOTSWANA
Phinius, Bonolo Bonita (Botswana)1; Bokete, Resego (Botswana)1; Anderson, Motswedi (Botswana)1,2; Mbangiwa, Tshepiso (Botswana)1,2; Choga, Wonderful (Botswana)1; Moyo, Sikhulile (Botswana)1,3; Musonda, Rosemary (Botswana)1,3; Marlink, Richard (Botswana)4; Gaseitsiwe, Simani (Botswana)1,3
1 - Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; 2 - University of Botswana, Gaborone, Botswana; 3 - Harvard T.H Chan School of Public Health, Boston, Massachusetts, USA; 4 - Rutgers University, New Jersey, USA
Kwena, Zachary
PO - (8550) - NATURE AND PREVALENCE OF MULTI-MORBIDITY IN FISHING COMMUNITIES ON LAKE VICTORIA, KENYA
Kwena, Zachary (Kenya)1; Ondondo, Raphael (Kenya)1; Makokha, Catherine (Kenya)1; Bukusi, Elizabeth (Kenya)1
1 - Kenya Medical Research Institute
Silva, Isaquel Bartolomeu
PO - (8572) - CAUSES OF HOSPITALIZATION AND MORTALITY IN CHILDREN UNDER 5 YEARS, NATIONAL HOSPITAL OF GUINEA-BISSAU, 2015-2017.
Silva, Isaquel Bartolomeu (Guinea-Bissau)1; Øland, Christian Bjerregård (Denmark)1
1 - Bandim Health Project
Japhet, Margaret
PO - (8585) - HIV, HBV AND HCV PREVALENCE, CO-INFECTIONS, RISK FACTORS AND AWARENESS AMONG STUDENTS IN A NIGERIAN UNIVERSITY
Japhet, Margaret (Nigeria)2; Adewumi, Moses (Nigeria)1; Adesina, Olufisayo (Nigeria)2
1 - Department of Virology, University College Hospital (UCH), University of Ibadan; 2 - Department of Microbiology, Faculty of Science, Obafemi Awolowo University
Vasconcelos, Alexandra
PO - (8592) - WHY, WHEN AND WHERE DO NEWBORNS NOT ONLY GET SICK BUT ALSO DIE IN SÃO TOMÉ PRÍNCIPE? A CASE-CONTROL STUDY
Vasconcelos, Alexandra (Portugal)1; Sousa, Swasilanne (Sao Tome and Principe)2; Bandeira, Nelson (Sao Tome and Principe)2; Baptista, João Luís (Portugal)3; Machado, Maria Do Céu (Portugal)4; Pereira, Filomena (Portugal)1
1 - Unidade de Clínica Tropical - Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa; 2 - Hospital Dr. Ayres de Menezes, República Democrática de São Tomé e Príncipe; 3 - Professor Convidado da Faculdade Ciências da Saúde, Universidade da Beira Interior; 4 - Professora de Pediatria da Faculdade de Medicina de Lisboa, Universidade de Lisboa
Monitor 2: Tuberculosis
E-poster Presentation
Sala / Room 2
Tadesse, Mulualem
PO - (8168) - CLINICAL UTILITY OF XPERT MTB/RIF ASSAY FOR THE DIAGNOSIS OF EXTRAPULMONARY TUBERCULOSIS IN ETHIOPIA
Tadesse, Mulualem (Ethiopia)1; Abeba, Gemeda (Ethiopia)2; Yilma, Daniel (Ethiopia)2; Apers, Ludwig (Belgium)3; De Jong, Bouke (Belgium)3; Rigouts, Leen (Belgium)3
1 - Mycobacteriology Research Center, Jimma University; 2 - Jimma University; 3 - Institute of Tropical Medicine
Motaung, Bongani
PO - (8179) - THE MEAN LEVELS OF ENDOPLASMIC RETICULUM (ER) STRESS CHAPERONE PROTEIN - BINDING IMMUNOGLOBULIN PROTEIN (BIP) DECREASES FOLLOWING SUCCESSFUL TB TREATMENT
Motaung, Bongani (South Africa)1; Loxton, Andre G. (South Africa)2
1 - Stellenboch University Immonology Research Group; 2 - Stellenbosch University Immunology Research Group
Massou, Faridath
PO - (8372) - CULTURE FREE APPROACHES FOR THE DIAGNOSTIC AND MANAGEMENT OF PATIENTS WITH RIFAMPICIN RESISTANT TUBERCULOSIS: THE DIAMA PROJECT
Massou, Faridath (Benin)1; Affolabi, Dissou (Benin)1; Merle, Corinne (Switzerland)2; Abebe, Gemeda (Ethiopia)3; Bah Sow, Oumou (Gabon)4; Diarra, Bassirou (Mali)5; El Tayeb, Osman (Nigeria)6; Gaye Diallo, Ayou (Senegal)7; Kaswa, Michel (Congo (the Democratic Republic of the))8; Jean Claude, Ngabonziza Semuto (Rwanda)9; Sander, Melissa (Cameroon)10; Supply, Philip (France)11; De Jong, Bouke (Belgium)12
1 - Supranational Reference Laboratory of Mycobacteria, Cotonou, Benin; 2 - Special Program for Research and Training in Tropical Diseases, World Health Organization (WHO/TDR), Switzerland, Geneva; 3 - Jimma University, Jimma, Ethiopia; 4 - Service de Pneumophtisiologie, Guinea, Conakry; 5 - Université des Sciences, des Techniques et des Technologies de Bamako, SEREFO, Mali, Bamako; 6 - Damian Foundation, Ibadan, Nigeria; 7 - Université Cheikh Anta Diop, Senegal, Dakar; 8 - Institut National de Recherche Biomédicale (INRB), Kinshasa, DRC; 9 - Rwanda Biomedical Center (RBC), Kigali, Rwanda; 10 - The Tuberculosis Reference Laboratory Bamenda, Cameroon; 11 - Genoscreen, France, Lille; 12 - Institute of Tropical Medicine (ITM), Belgium, Antwerp
Gindeh, Awa
PO - (8383) - THE ROLE OF PLASMA B CELLS IN MYCOBACTERIUM TUBERCULOSIS INFECTION AND DISEASE
Gindeh, Awa (Gambia)1; Donkor, Simon (Gambia)1; Owolabi, Olumuyiwa (Gambia)1
1 - Medical Research Council, Gambia Unit @ LSHTM
Omer, Mona
PO - (8392) - SPUTUM MYCOBACTERIUM LOAD AND CYTOKINES BIOMARKER OF STIMULATED WHOLE BLOOD CELLS IN SPUTUM SMEAR NEGATIVE PULMONARY TUBERCULOSIS SUDANESE PATIENTS.
Omer, Mona (Sudan)1
1 - Institute of Endemic Diseases - University of Khartoum
Faburay, Alieu K
PO - (8414) - EVALUATION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX CULTURE METHODS IN MYCOBACTERIUM AFRICANUM SPECIFIC ENDEMIC REGION OF WEST AFRICA
Faburay, Alieu K (Gambia)1; Mendy, Francis S (Gambia)1; Gibba, Sarjo A (Gambia)1; Lamin, Modou (Gambia)1; Sambou, Basil (Gambia)1; Mendy, Alieu (Gambia)1; Faal-Jawara, Tutty Isatou (Gambia)1; Gehre, Florian (Gambia)2; Sutherland, Jayne (Gambia)1; Kampmann, Beate (Gambia)1; Secka, Ousman (Gambia)1
1 - MRCG at LSHTM; 2 - Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany
Ssengooba, Willy
PO - (8468) - DETERMINE TB –LAM LATERAL FLOW ASSAY, DOES M. TUBERCULOSIS LINEAGE INFLUENCE ITS PERFORMANCE?
Ssengooba, Willy (Uganda)1; Nakiyingi, Lydia (Uganda)2; Joloba, Moses (Uganda)1
1 - Department of Medical Microbiology, College of Health Sciences Makerere University Kampala, Uganda; 2 - Infectious Diseases Institute, College of Health Sciences Makerere University, Kampala, Uganda
Rakotosamimanana, Niaina
PO - (8518) - LATENT TUBERCULOSIS INFECTION DETECTION BY IGRA USING MYCOBACTERIUM TUBERCULOSIS ALTERNATIVE DESATURASE A1 IMMUNE-DOMINANT ANTIGEN
Rakotosamimanana, Niaina (Madagascar)1; Doherty, Mark (Belgium)2; Raharimanga, Vaomalala (Madagascar)1; Richard, Vincent (Madagascar)1; Gicquel, Brigitte (France)1; Zumla, Alimuddin (United Kingdom)3; Rasolofo, Voahangy (Madagascar)1
1 - Institut Pasteur de Madagascar; 2 - GlaxoSmithKline; 3 - University College London
Ayorinde, Abigail
PO - (8596) - ENHANCING LABORATORY DIAGNOSIS OF MYCOBACTERIUM TUBERCULOSIS IN SAMPLES FROM CHILDREN IN THE GAMBIA
Ayorinde, Abigail (Gambia)1; Coker, Edward G. (Gambia)1; Mendy, Alieu (Gambia)1; Cole, Fatoumatta (Gambia)1; Sillah, Abdou K. (Gambia)1; Mendy, Francis S. (Gambia)1; Egere, Uzochukwu (Gambia)1; Kampmann, Beate (Gambia)1,2; Tientcheu, Leopold D. (Gambia)1,3
1 - Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine; 2 - Imperial College, London; 3 - Department of Biochemistry, Faculty of Science University of Yaoundé 1
Monitor 3: HIV
E-poster Presentation
Sala / Room 2
Ekwunife, Obinna
PO - (7139) - CONDITIONAL ECONOMIC INCENTIVES AND MOTIVATIONAL INTERVIEWING TO IMPROVE ADOLESCENTS’ RETENTION AND ADHERENCE TO ANTIRETROVIRAL THERAPY IN NIGERIA: ARA TRIAL
Ekwunife, Obinna (Nigeria)1; Anetoh, Maureen (Nigeria)1; Kalu, Stephen (Nigeria)2; Eleje, George (Nigeria)1
1 - Nnamdi Azikiwe University; 2 - Nnamdi Azikiwe University Teaching Hospital
Andrew, Nifarta
PO - (8171) - PREDICTORS OF LOST TO FOLLOW-UP IN ART COMMENCED PATIENTS IN NIGERIA: A 13-YEAR REVIEW (2004-2017)
Aliyu, Ahmad (Nigeria)1; Adelekan, Babatunde (Nigeria)1; Andrew, Nifarta (Nigeria)1; Ekong, Eunice (Nigeria)1; Dapiap, Stephen (Nigeria)1; Murtala-Ibrahim, Fati (Nigeria)1; Ndembi, Nicaise (Nigeria)1; Nta, Iboro (Nigeria)1; Mensah, Charles (Nigeria)1; Dakum, Patrick (Nigeria)1
1 - INSTITUTE OF HUMAN VIROLOGY, NIGERIA
Abongwa, Lem Edith
PO - (8190) - RISK FACTORS OF SEVERE HEPATOTOXICITY AMONG HIV-1 PATIENTS INITIATED ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN THE NORTHWEST REGION OF CAMEROON
Abongwa, Lem Edith (Cameroon)1; Kibera, Anthony N (Kenya)5; Charles, Fokunang (Cameroon)2; Torimiro, Judith (Cameroon)2; Emmanuel, Nshom (Cameroon)3; Domkam, Irénée (Cameroon)4; Okemo, Paul (Kenya)5
1 - University of Bamenda, Faculty of Science, Bambili, Cameroon; 2 - Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé; 3 - Mbingo Baptist Hospital, Bamenda, Cameroon; 4 - Chantal Biya International Center for Research on the Prevention and Management of HIV / AIDS(CIRCB), Cameroon; 5 - Department of Microbiology, School of Pure and Applied Sciences, Kenyatta University, Nairobi, Kenya.
Lisboa, Miguelhete
PO - (8276) - COMMUNITY INDEX CASE APPROACH AND HTC FOR SEXUAL PARTNERS OF HIV+ PATIENTS LOST TO FOLLOW-UP: EXPERIENCE OF WORLD VISION, MOZAMBIQUE
Lisboa, Miguelhete (Mozambique)1; Culuze, Saraiva (Mozambique)1; Imputiua, Saimado (Mozambique)1; Cambule, Adolfo (Mozambique)1; Latif, Christine (Mozambique)1
1 - World Vision Mozambique
Lisboa, Miguelhete
PO - (8296) - REDUCING LOSS OF FOLLOW-UP OF CHILDREN EXPOSED TO HIV IN THE PROVINCES OF MANICA AND SOFALA- CENTER OF MOZAMBIQUE
Vieira, Lúcia Da Costa (Mozambique)1; Mahumane, Arlete (Mozambique)1; Lisboa, Miguelhete (Mozambique)2
1 - Beira Operational Research Center; 2 - World Vision Mozambique
Fokam, Joseph
PO - (8397) - VIRAL SUPPRESSION AMONG CAMEROONIAN ADULTS, ADOLESCENTS AND CHILDREN RECEIVING ANTIRETROVIRAL THERAPY IN THE “TEST & TREAT” ERA
Fokam, Joseph (Cameroon)1; Sosso, Samuel Martin (Cameroon)1; Djubgang Mbadie, Rina Estelle (Cameroon)2; Bouba, Yagai (Cameroon)1; Kamgaing Simo, Rachel (Cameroon)1; Edimo, Serge Valery (Cameroon)2; Nka, Alex Durand (Cameroon)1; Fokam, Tiga Ayissi (Cameroon)1; Junie Flore, Yimga (Cameroon)1; Désiré Augustin, Takou Komego (Cameroon)1; Sylvie, Moudourou (Cameroon)1; Marinette, Ngo Nemb (Cameroon)2; Serge Clotaire, Billong (Cameroon)2; Jean-Bosco, Nfetam Elat (Cameroon)2; Colizzi, Vittorio (Cameroon)3; Alexis, Ndjolo (Cameroon)1
1 - CIRCB: Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management; 2 - Central Technical Group, National AIDS Control Committee; 3 - UNESCO BOARD of Biotechnology, University of Rome Tor Vergata, Rome, Italy
Sumari-De Boer, I Marion
PO - (8476) - USER EXPERIENCE OF SMS REMINDERS TO TAKE MEDICATION AMONG PREGNANT AND BREASTFEEDING WOMEN LIVING WITH HIV IN KILIMANJARO, TANZANIA
Ngowi, Kennedy M (Tanzania)1; Maro, Eusibious (Tanzania)2; Nieuwkerk, Pythia T (Netherlands)3; Aarnoutse, Rob E (Netherlands)4; Mmbaga, Blandina T (Tanzania)1,2; Sumari-De Boer, I Marion (Tanzania)1,5
1 - Kilimanjaro Clinical Research Institute, Moshi, Tanzania; 2 - Kilimanjaro Christian Medical Center, Moshi, Tanzania; 3 - Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands; 4 - Department of Pharmacy and with the Radboud Institute for Health Sciences, RadboudUMC, Nijmegen, the Netherlands; 5 - Department of International Health, RadboudUMC, Nijmegen, the Netherlands
Fokam, Joseph
PO - (8580) - TREATMENT RESPONSE AMONG CAMEROONIAN ADOLESCENTS RECEIVING ANTIRETROVIRAL THERAPY IN URBAN AND RURAL SETTINGS: PRELIMINARY FINDINGS FROM THE READY-STUDY (EDCTP-CDF-1027)
Fokam, Joseph (Cameroon)1; Takou, Desire (Cameroon)1; Santoro, Maria (Cameroon)2; Nangmo, Armanda (Cameroon)3; Sosso, Samuel Martin (Cameroon)1; Teto, Georges (Cameroon)1; Colizzi, Vittorio (Italy)2; Perno, Carlo-Fedrico (Italy)2; Ndjolo, Alexis (Cameroon)1; The Ready-Study, Georges (Cameroon)1
1 - CIRCB: Chantal BIYA International Reference Center for research on HIV/AIDS prevention and management; 2 - University of Rome Tor Vergata; 3 - Faculty of Health Sciences, University
Angira, Francis
PO - (8595) - FACTORS ASSOCIATED WITH VIROLOGIC FAILURE AMONG WOMEN WITH PRIOR EXPOSURE TO ANTIRETROVIRAL DRUGS FOR PMTCT, KISUMU, KENYA
Angira, Francis (Kenya)1,3; Awuonda, Eucabeth (Kenya)1; Oruko, Jacinter (Kenya)1; Boaz, Oyaro (Kenya)1; Asadhi, Elijah (Kenya)2; Olilo, George (Kenya)1
1 - Kenya Medical Research Institute-Center for Global Health Research; 2 - United Nations Children's Fund (UNICEF), Kenya; 3 - East African Consortium for Clinical Research
13:30
13:45
One go-to place for grantees: introducing the EDCTP Knowledge Hub
Launch Event
Sala / Room 4
Organiser: The Global Health Network (United Kingdom)
14:00
15:30
Malaria Vaccines
Parallel Session
Auditorium 1
Sirima, Sodiomon
OC - (8546) - SAFETY AND IMMUNOGENICITY OF THE MALARIA VACCINE CANDIDATE BK-SE36 IN YOUNG CHILDREN LIVING IN BURKINA FASO
Sirima, Sodiomon (Burkina Faso)1; Tiono, Alfred .B (Burkina Faso)1; Houard, Sophie (Belgium)2; Bougouma, Edith .C (Burkina Faso)1; Coulibaly, Sam .A (Burkina Faso)1; Leroy, Odile (Japan)2; Palacpac, Nirianne (Japan)3; Horii, Toshihiro (Japan)3; Ouedraogo, Issa .N (Burkina Faso)1
1 - Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso; 2 - European Vaccine Initiative, Heidelberg, Germany; 3 - Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
Gamain, Benoit
OC - (8582) - A PHASE IA/B STUDY TO ASSESS SAFETY AND IMMUNOGENICITY OF PLACENTAL MALARIA VACCINE CANDIDATE: PRELIMINARY RESULTS OF THE PRIMALVAC TRIAL
Konate, Amadou (Burkina Faso)1; Richert, Laura (France)2; Chêne, Arnaud (France)3; Semblat, Jean-Philippe (France)3; Roguet, Gwenaelle (France)4; Benhamouda, Nadine (France)5; Bahuaud, Mathilde (France)6; Havelange, Nicolas (Germany)7; Kuppers, Alexis (France)8; Campion, Cécilia (France)2; Boilet, Valérie (France)2; Gueguen, Sonia (France)8; Loulergue, Pierre (France)4; Leroy, Odile (France)7; Batteux, Frederic (France)6; Tartour, Eric (France)5; Viebig, Nicola (Germany)7; Thiebaut, Rodolphe (France)2; Sirima, Sodiomon B. (Burkina Faso)1; Launay, Odile (France)4; Gamain, Benoit (France)3
1 - Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso; 2 - EUCLID/F-CRIN, Université, CHU Bordeaux, INSERM, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France; 3 - INSERM U1134, Université Paris Diderot Sorbonne Paris-Cité, Paris, France; 4 - Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France; 5 - INSERM U970, Université Paris Descartes Sorbonne Paris-Cité, Hôpital Européen Georges Pompidou, Paris, France; 6 - Université Paris Descartes, Sorbonne Paris Cité AP-HP, Département d'Immunologie Biologique, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Paris, France; 7 - European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Heidelberg, Germany; 8 - INSERM Pôle de Recherche Clinique, Paris, France
Ouedraogo, Alphonse
OC - (8552) - EFFICACY OF THE CHAD63-MVA ME-TRAP VECTORED MALARIA VACCINE CANDIDATE IN 5-17 MONTHS OLD INFANTS AND CHILDREN IN BURKINA FASO
Tiono, B.Alfred (Burkina Faso)1; Nebie, Issa (Burkina Faso)1; Anagnostou, Nicholas (United Kingdom)2; Coulibaly, Aboubacar S. (Burkina Faso)1; Lawrie, Alison (United Kingdom)2; Bougouma, Edith C (Burkina Faso)1; Ouedraogo, Alphonse (Burkina Faso)1; Yaro, Jean Baptist (Burkina Faso)1; Barry, Aïssata (Burkina Faso)1; Roberts, Rachel (United Kingdom)2; Ouedraogo, Amidou (Burkina Faso)1; Ewer, Katie J. (United Kingdom)2; Viebig, Nicola K. (Germany)3; Diarra, Amidou (Burkina Faso)1; Leroy, Odile (Germany)3; Bejon, Philip (United Kingdom)2; Hill, Adrian (United Kingdom)2; Sirima, Sodiomon B. (Burkina Faso)1
1 - Centre National de Recherche et de Formation sur le Paludisme (CNRFP); 2 - Centre for Clinical Vaccinology and Tropical Medicine University of Oxford Churchill Hospital, Oxford; 3 - European Vaccine Initiative, Universitäts Klinikum Heidelberg, Heidelberg
Khan, Shahid
OC - (8743) - THE GENERATION AND TESTING OF A GENETICALLY ATTENUATED MALARIA PARASITE (GAP) VACCINE
Khan, Shahid (Netherlands)1
1 - Leiden University Medical Center
14:00
15:30
Breaking barriers: opportunities and challenges in building partnerships for product development
Parallel Session
Auditorium 2
Background
The aim is to understand opportunities and challenges of the process and to identify approaches how to remove potential roadblocks to ensure the successful development of accessible and affordable products, particularly when underserved populations are targeted (paediatric, pregnant women, adolescent).
Objectives
The objective of this session is to discuss how collaborative partnerships with product developers, encompassing large international pharmaceutical corporations, small- and medium sized biotechnology companies as well as PDPs, can accelerate product development of medical interventions targeting PRDs in sub-Saharan Africa by adopting an “end-to-end” strategy that includes the regulatory aspect and access to medicine.
1. Discuss the role and approach of each partner presented by the panelist in the fight against PRDs among underserved populations in sub-Saharan Africa.
2. Discuss how industry/private sector, PDPs, EMA, EDCTP and other funders can partner with each other and with other stakeholders (e.g. public sector) to accelerate the development and access of medical interventions for PRDs (have an “end-to-end strategy” on mind)
3. Highlight the challenges but also opportunities for the private sector/stakeholder to engage in partnerships
4. Identify potential areas of collaboration with EDCTP
Private Sector: engagement with partners for product development targeting PRDs
Jutta Reinhard-Rupp, Merck Serono (Switzerland)
Ingrid Murillo, Biofabri SL (Spain)
PDPs: a model for strategic collaborations with the public and private sector to ensure equitable access of new products
Wiweka Kaszubska, Medicines for Malaria Venture
(MMV, Swtizerland)
Swati Gupta, International Aids Vaccine Initiative (IAVI,
United States of America)
Access to Medicines
Agnes Saint-Raymond, European Medicines Agency
(United Kingdom)
Ahmed Bellah, WHO (Switzerland)
14:00
15:30
Partnerships and capacity building
Parallel Session
Auditorium 3
Munung, Nchangwi Syntia
OC - (8360) - GLOBAL HEALTH RESEARCH AND ITS ROLE IN IMPROVING HEALTH AND HEALTH EQUITY IN AFRICA
Munung, Nchangwi Syntia (South Africa)1; De Vries, Jantina (South Africa)1; Pratt, Bridget F (Australia)2
1 - Department of Medicine, University of Cape Town; 2 - Nossal Institute for Global Health and Centre for Health Equity, School of Population and Global Health, The University of Australia
Abade, Leandro
OC - (8477) - MAKING RESEARCH EASIER, BETTER AND FASTER THROUGH KNOWLEDGE SHARING AND BUILDING COMMUNITIES OF PRACTICE
Abade, Leandro (United Kingdom)1
1 - The Global Health Network
Noormahomed, Emilia
OC - (8566) - THE UNIVERSIDADE EDUARDO MONDLANE AND UNIVERSITY OF CALIFORNIA SAN DIEGO PARTNERSHIP, A PARADIGM FOR INSTITUTIONAL AND HUMAN RESOURCES CAPACITY BUILDING
Noormahomed, Emilia (Mozambique)1; Scooley, Robert (Mozambique)2
1 - Universidade Eduardo Mondlane; 2 - University of california San Diego
Musabyimana, Jean Pierre
OC - (8526) - THE RWANDA CLINICAL RESEARCH NETWORK (RWANDA-CRN): A MODEL FOR MIXED SOUTH-SOUTH AND NORTH-SOUTH COLLABORATIONS FOR CLINICAL RESEARCH CAPACITY DEVELOPMENT
Musabyimana, Jean Pierre1; Musanabaganwa, Clarisse (Rwanda)1; Musabyimana, Jean Pierre (Rwanda)1; Dushimiyimana, Valentine (Rwanda)1; Namabajimana, Jean Pierre (Rwanda)1; Karame, Pprosper (Rwanda)1; Nshimiyimana, Ladislas (Rwanda)1; Ndishimye, Pacific (Rwanda)1
1 - Rwanda Biomedical Center - Ministry of Health
14:00
15:30
Neglected infectious diseases
Parallel Session
Sala / Room 4
Geluk, Annemieke
OC - (8244) - QUANTITATIVE LATERAL FLOW ASSAY FOR DETECTION OF M. LEPRAE INFECTION USING FINGERSTICK BLOOD
Geluk, Annemieke (Netherlands)1; Van Hooij, Anouk (Netherlands)1; Tjon El Fat2, Elisa (Netherlands)1; Alam, Kosrhed (Bangladesh)2; Dlamini, Sipho (South Africa)4; Batista Da Silva, Moises (Brazil)3; Spencer, John (United States of America)5; Salgado, Claudio (Brazil)3; Richardus, Jan Hendrik (Netherlands)6; Corstjens, Paul (Netherlands)1
1 - Leiden University Medical Center; 2 - The Leprosy Mission Rural Health program; 3 - Universidade Federal do Pará; 4 - Groote Schuur Hospital; 5 - Colorado State University; 6 - Erasmus MC, University Medical Center Rotterdam
Mubanga, Chishimba
OC - (8432) - EVALUATION OF AN ANTIBODY-DETECTING POINT-OF-CARE TEST FOR THE DIAGNOSIS OF TAENIA SOLIUM TAENIASIS AND NEUROCYSTICERCOSIS/CYSTICERCOSIS IN AN ENDEMIC AREA
Mubanga, Chishimba (Zambia)1; Mwape, Kabemba (Zambia)1; Zulu, Gideon (Zambia)2; Phiri, Isaac (Zambia)1; Trevisan, Chiara (Belgium)3; Dorny, Pierre (Belgium)3; Gabriel, Sarah (Belgium)4; Van Damme, Inge (Belgium)4
1 - The University of Zambia, School of Veterinary Medicine, Department of Clinical services; 2 - Ministry of Health; 3 - Institute of Tropical Medicine, Antwerp; 4 - University of Ghent
Thelingwani, Roslyn Stella
OC - (8510) - BIOTRANSFORMATION OF PRAZIQUANTEL FOR THE PHARMACOKINETIC OPTIMIZATION OF PRAZIQUANTEL USE IN MASS DRUG ADMINISTRATION AND DEVELOPMENT OF NEW PEDIATRIC FORMULATIONS.
Thelingwani, Roslyn Stella (Zimbabwe)1; Kapungu, Nyasha (Zimbabwe)1; Li, Xueqing (Sweden)2; Kanji, Comfort (Zimbabwe)1; Mutiti, Chenai (Zimbabwe)1; Reinhard-Rupp, Wilma Jutta (Germany)3; Masimirembwa, Collen (Germany)1
1 - African Institute of Biomedical Science and Technology; 2 - AstraZeneca; 3 - EMD Serono
Frimpong, Michael
OC - (8173) - RAPID DETECTION OF MYCOBACTERIUM ULCERANS BY RECOMBINASE POLYMERASE AMPLIFICATION
Frimpong, Michael (Ghana)1; Ahor, Hubert (Ghana)1; Sarpong, Francisca (Ghana)1; Laing, Ken (United Kingdom)2; Wansbrough-Jones, Mark (United Kingdom)2; Phillips, Richard (Ghana)1
1 - Kumasi Centre for Collaborative Research in Tropical Medicine; 2 - St. George's University of London
15:30
16:00
Coffee Break
Break
Foyer 1
16:00
17:45
Plenary Session III
Plenary Session
Auditorium 1
Feedback from the high-level meeting of EDCTP Participating Stated and strategic partners
Auditorium 1
Mark Palmer - Chair of EDCTP Board and General Assembly
Horizon Europe - what's in it for global health, a civil society perspective
Auditorium 1
Lisa Goerlitz - DSW (Deutsche Stiftung Weltbevoelkerung)
Opportunities and recommendations for an EDCTP successor programme
Auditorium 1
Detlef Böcking - German Federal Ministry of Education and Research
Khadija Yahya-Malima - Tanzania Commission for Science and Technology (COSTECH)
Lisa Goerlitz - DSW (Deutsche Stiftung Weltbevoelkerung)
Alexandra Fullem - Global Health Consultant
19:30
21:00
Ninth EDCTP Forum Dinner
Social Programme
Lisbon Marriott Hotel
Address: Av. dos Combatentes 45, 1600-042 Lisboa
Wednesday, 19 September 2018
08:00
18:00
Registration
Registration Desk
09:00
10:00
Plenary Session IV
Plenary Session
Auditorium 1
Tribute to Professor Bongani Mayosi: a lasting contribution to cardiovascular research and capacity building in Africa
Professor Bongani Mayosi was an academic leader of great distinction, a brilliantcardiologist, a globally recognised clinical scientist, and a well-loved teacher.
His research focused on addressing poverty-related heart diseases through advancing the understanding of genetics of cardiovascular traits, the treatment
of tuberculous pericarditis, and the prevention of rheumatic fever.
Professor Mayosi served as Head of the Department of Internal Medicine from 2006 to 2015 and Dean of the Faculty of Health Sciences of the University of Cape Town (UCT), South Africa from 2016. In 2009, he received the South Africa’s highest honour, the Order of Mapungubwe for service to medical science and was elected member to the US National Academy of Medicine in 2017.
Tribute to Professor Bongani Mayosi: a lasting contribution to cardiovascular research and capacity building in Africa
Plenary Session
Auditorium 1
10:00
10:30
Coffee Break
Break
Foyer 1
10:30
12:30
Malaria prevention and treatment
Parallel Session
Auditorium 2
Brito, Catarina
OC - (8415) - A TRANSLATIONAL PRECLINICAL PLATFORM TO ASSESS THE CHEMOPROPHYLAXIS AND CHEMOPREVENTION DOSE-RELATIONSHIP OF MALARIA DRUGS: THE CASE STUDY OF M5717
Rebelo, Sofia (Portugal)1; Simão, Daniel (Portugal)1; Arez, Franscisca (Portugal)1; Fontinha, Diana (Portugal)2; Machado, Marta (Portugal)2; Martins, Tatiana (Portugal)1; Fischli, Christoph (Switzerland)3; Oeuvray, Claude (Switzerland)4; Carrondo, Manuel (Portugal)1; Rottman, Matthias (Switzerland)3; Spangenberg, Thomas (Switzerland)4; Brito, Catarina (Portugal)1; Greco, Beatrice (Switzerland)4; Prudencio, Miguel (Portugal)2; Alves, Paula M (Portugal)1
1 - Instituto de Biologia Experimental e Tecnológica; 2 - Instituto de Medicina Molecular; 3 - Swiss Tropical and Public Health Institute; 4 - Merck Global Health Institute
Phiri, Kamija
OC - (8568) - A RANDOMIZED CONTROLLED TRIAL OF ORAL IRON FOR TREATMENT OF POST-MALARIA ANAEMIA IN MALAWIAN CHILDREN COMPARING IMMEDIATE VERSUS DELAYED ADMINISTRATION
Phiri, Kamija (Malawi)1; Longwe, Herbert (Malawi)1; White, Sarah (Malawi)1; Esan, Michael (Malawi)1; Ter Kuile, Feiko (United Kingdom)2; Brabin, Bernard (United Kingdom)2
1 - College of Medicine, University of Malawi; 2 - Liverpool School of Tropical Medicine
Ndong, Ignatius Cheng
OC - (8453) - SCALING-UP MASS TESTING AND TREATMENT EFFECTIVELY REDUCED MALARIA ASYMPTOMATIC PARASITAEMIA IN CHILDREN <15 IN GHANA.
Ndong, Ignatius Cheng (Ghana)1; Ahorlu, Collins Stephan (Ghana)1; Okyere, Daniel (Ghana)1; Nyarko, Alexander A. (Ghana)1; Amambua-Ngwa, Alfred (Gambia)2; Koram, Kwakwo A. (Ghana)1
1 - Noguchi Memorial Institute for Medical Research, University of Ghana; 2 - Medical Research Council, The Gambia
Soulama, Issiaka
OC - (8459) - ASSESSMENT OF PARASITE CLEARANCE AFTER REPEATED TREATMENT WITH ARTESUNATE AMODIQUINE, DIHYDROARTEMINININE-PIPERAQUINE, PYRONARIDINE-ARTESUNATE IN MALARIA PATIENTS IN BURKINA FASO
Soulama, Issiaka (Burkina Faso)1; Sirima, Sodiomon B (Burkina Faso)1
1 - Centre National de Recherche et de Formation sur le Paludisme
Djimde, Abdoulaye
OC - (8742) - WANECAM II – A CLINICAL TRIAL PROGRAM TO ASSESS SAFETY, EFFICACY AND TRANSMISSION-BLOCKING PROPERTIES OF A NEW ANTIMALARIAL KAF156 (GANAPLACIDE) IN UNCOMPLICATED MALARIA IN WEST AND CENTRAL AFRICA
Djimde, Abdoulaye (Mali)1; Grobusch, Martin (Netherlands)2; Zoleko Manego, Rella (Gabon)3; Mombo Ngoma, Ghyslain (Gabon)3; Picot, Stephane (France)4; Sagara, Issaka (Mali)1; Sutherland, Colin (United Kingdom)5; Kone, Aminatou (United Kingdom)1; Doumbo, Ogobara (United Kingdom)1; Gil, Jose Pedro (Sweden)6; Björkman, Anders (Sweden)6; Borrmann, Steffen (Germany)7; Soulama, Issiaka (Burkina Faso)8; Fofana, Bakary (Mali)1; Duparc, Stephane (Switzerland)9; Dicko, Alassane (Mali)1; Hughes, David (Switzerland)10; Winnips, Cornelis (Switzerland)10; Bienvenu Sirima, Sodiomon (Burkina Faso)11; Adehossi, Eric (Niger)12; Ouedraogo, Jean-Bosco (Mali)1; Dembele, Laurent (Mali)1; Zongo, Dr Issaka (Burkina Faso)8; Biguenet, Sophie (Switzerland)9; Ilboudo-Sanogo, Edithe (Burkina Faso)11; Fofana, Aminata (Burkina Faso)8
1 - Université des Sciences, des Techniques et des Technologies de Bamako (USTTB); 2 - Academic Medical Center (AMC); 3 - Centre de Recherches Médicales en Lambaréné (CERMEL); 4 - University Lyon; 5 - London School of Hygiene & Tropical Medicine; 6 - Karolinska Institute (KI); 7 - Eberhard Karls Universität Tübingen; 8 - Institut des Sciences et Techniques (INSTech); 9 - Medicines for Malaria Venture (MMV); 10 - Novartis Pharma AG, Basel; 11 - Groupe de Recherche Action en Santé (GRAS); 12 - University Abdou Moumouni of Niamey
10:30
12:30
Ethics
Parallel Session
Auditorium 3
Singh, Michelle
OC - (8744) - CREATING AND ENHANCING TRUSTWORTHY, RESPONSIBLE AND EQUITABLE PARTNERSHIPS IN INTERNATIONAL RESEARCH
Singh, Michelle (Netherlands)1; Makanga, Michael (Netherlands)1
1 - EDCTP Secretariat
Ouchhi, Samira
OC - (8391) - AFREENET (AFRICA ETHICS EXCELLENCE NETWORK): A NETWORK OF NATIONAL RESEARCH ETHICS COMMITTEES ENGAGED IN THE REINFORCEMENT OF THEIR CAPACITIES
Pirard, Virginie (France)1; Penali, Louis (Côte d'Ivoire)2; Gangbo, Armande (Benin)4; Younoussa Sow, Oumou (Guinea)3; Ouchhi, Samira (France)1
1 - Institut Pasteur; 2 - NEC Côte d'Ivoire; 3 - NEC Guinea; 4 - NEC Benin
Oliveira Martins, Maria Rosario
OC - (8535) - AN OVERVIEW OF RESEARCH ETHICS COMMITTEES OPERATING IN LUSOPHONE AFRICAN COUNTRIES
Oliveira Martins, Maria Rosario (Portugal)1; Schwalbach, Joao (Mozambique)2; Sevene, Esperança (Mozambique)3; Martins, Antonieta (Cape Verde)4; Branco Fernandes, Ema Candida (Angola)5; Araujo, Isabel Ines (Cape Verde)4; Pereira De Melo, Helena (Portugal)6; Tome Da Silva, Amilcar Bernardo (Angola)5; Catumbela, Emanuel (Angola)5; Sacarlal, Jahit (Mozambique)3; Seixas, Jorge (Portugal)1; Chimpolo, Maria (Angola)5; Nala, Rassul (Mozambique)2; Tazi Nimi, Maria (Angola)5; Rodrigues, Amabelia (Guinea-Bissau)7
1 - Global Health and Tropical Medicine Instituto de Higiene e Medicina Tropical Universidade NOVA de Lisboa; 2 - Comité Nacional de Bioética para a Saúde de Moçambique; 3 - Comité Nacional de Bioética para a Saúde de Moçambique , Faculdade de Medicina, Universidade Eduardo Mondlane; 4 - Universidade de Cabo Verde; 5 - Faculdade de Medicina, Universidade Agostinho Neto , Comité Independente de Etica; 6 - Faculdade de Direito, Universidade Nova de Lisboa , Conselho de Ética da Universidade NOVA; 7 - Projeto saude Bandim, guiné-Bissau, Comite Nacional etica para a saúde
Twungubumwe, Novat
OC - (8474) - ASSESSMENT OF ETHICS REVIEW FRAMEWORKS FOR HEALTH RESEARCH IN EAST AFRICA FOR PURPOSES OF HARMONIZATION
S.Kibiki, Gibson (Burundi)1; Twungubumwe, Novat (Burundi)1; Kombe, Francis (Kenya)2; I Jsselmuiden, Carel (Switzerland)2; N.Bahati, Prince (Kenya)3; Kamali, Anatoli (Kenya)3; Ngirabega, Jean De Dieu (Burundi)1
1 - East African Health Research Commission; 2 - Council on Health Research for Development; 3 - International AIDS Vaccine Initiative
Djuidje Ngounoue, Marceline
OC - (8378) - REQUIREMENTS FOR THE ETHICAL CONDUCT OF CLINICAL RESEARCH IN CAMEROON, SUB-SAHARAN AFRICA: THE IMPORTANCE OF ACTIVE MONITORING
Djuidje Ngounoue, Marceline (Cameroon)1; Ateudjieu, Jerome (Cameroon)2; Fokunang, Charles (Cameroon)1; Chi, Primus Che (Norway)3; Ndje Ndje, Mireille (Cameroon)1; Kwedi Nolna, Sylvie (Cameroon)1; Magne, Gisele (Cameroon)4; Kaptue, Lazare (Cameroon)5,6
1 - University of Yaounde I; 2 - University of Dschang; 3 - Peace Research Institute Oslo (PRIO); 4 - Clinique Bastos; 5 - Universite des Montagnes; 6 - Cameroon National Ethics Committee
10:30
12:30
TB diagnostics
Parallel Session
Sala / Room 4
Reither, Klaus
OC - (8215) - DIAGNOSTIC ACCURACY OF XPERT MTB/RIF ULTRA FOR PULMONARY TUBERCULOSIS IN CHILDREN: A MULTICENTRE COMPARATIVE STUDY
Sabi, Issa (Tanzania)1; Rachow, Andrea (Germany)2,3; Mapamba, Daniel (Tanzania)1; Clowes, Petra (Tanzania)1; Ntinginya, Nyanda (Tanzania)1; Sasamalo, Mohamed (Tanzania)4; Kamwela, Lujeko (Tanzania)4; Haraka, Frederick (Tanzania)4,5,6; Hoelscher, Michael (Germany)2,3; Paris, Daniel (Switzerland)5,6; Saathoff, Elmar (Switzerland)2,3; Reither, Klaus (Switzerland)4,5,6
1 - NIMR-Mbeya Medical Research Center, Mbeya, United Republic of Tanzania; 2 - Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany; 3 - German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; 4 - Ifakara Health Institute, Bagamoyo, United Republic of Tanzania; 5 - Swiss Tropical and Public Health Institute, Basel, Switzerland; 6 - University of Basel, Basel, Switzerland
Manyelo, Masilo Charles
OC - (8277) - IDENTIFICATION OF NEW CEREBROSPINAL FLUID AND BLOOD-BASED BIOMARKERS FOR THE DIAGNOSIS OF TUBERCULOUS MENINGITIS IN CHILDREN
Manyelo, Masilo Charles (South Africa)1; Solomons, Regan S (South Africa)2; Walzl, Gerhard (South Africa)1; Chegou, Novel N (South Africa)1
1 - Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; 2 - Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Corstjens, Paul
OC - (8435) - MULTI-BIOMARKER TEST STRIP FOR POINT-OF-CARE SCREENING FOR ACTIVE TUBERCULOSIS: A FIVE COUNTRY MULTI-CENTER TEST EVALUATION
Corstjens, Paul (Netherlands)1; Van Hooij, Anouk (Netherlands)1; Tjon Kon Fat, Elisa (Netherlands)1; Herdigein, Shannon (Netherlands)1; Namuganga, Anna Ritah (Uganda)5; Diergaardt, Azaria (Namibia)6; Mutavhatsindi, Hygon (South Africa)2; Gindeh, Awa (Gambia)3; Mihret, Adane (Ethiopia)4; Van De Spuy, Gian (South Africa)2; Gunther, Gunar (Namibia)6; Howe, Rawleigh (Ethiopia)4; Mayanja-Kizza, Harriet (Uganda)5; Sutherland, Jayne (Gambia)3; Chegou, Novel (South Africa)2; Ottenhoff, Tom (Netherlands)1; Walzl, Gerhard (South Africa)2; Geluk, Annemieke (Netherlands)1
1 - Leiden University Medical Center; 2 - Stellenbosch University; 3 - Medical Research Council; 4 - Armauer Hansen Research Institute; 5 - Makerere University School of Medicine; 6 - University of Namibia School of Medicine
Sutherland, Jayne
OC - (8405) - IDENTIFICATION OF AN MTB-SPECIFIC SOLUBLE HOST SIGNATURE FOR RISK OF DEVELOPMENT OF ACTIVE TB IN HIV+ MTB-EXPOSED CONTACTS
Mendy, Joseph (Gambia)1; Chegou, Novel (South Africa)2; Mayanja-Kizza, Harriet (Uganda)3; Stanley, Kim (South Africa)2; Thiel, Bonnie (United States of America)4; Ottenhoff, Tom (Netherlands)5; Kaufmann, Stefan (Germany)6; Boom, Henry (United States of America)4; Walzl, Gerhard (South Africa)2; Sutherland, Jayne (Gambia)1
1 - MRC Unit The Gambia at LSHTM; 2 - SUN; 3 - MAK; 4 - CWRU; 5 - LUMC; 6 - MPIIB
12:30
14:00
Lunch
Break
Foyer 1
12:30
13:30
Meet the Experts Lunch
Foyer 2
The aim of this session is to provide an informal atmosphere where
delegates can interact with experts over lunch to exchange knowledge
and insight, as well as gain networking opportunities. Topics such as
the challenges and opportunities of careers in health research will be
discussed. Pre-registration is required.
Professor Ayola Akim Adegnika
by registration only
Foyer 2
Professor Adegnika is currently full Professor of immuno-epidemiology and clinical research of infectious diseases at University of Tuebingen and research group leader of immuno-epidemiology of infectious diseases and director of the Centre de Recherches Médicales de Lambaréné, in Gabon. He is a Principal Investigator (PI) of some phase I to phase III anti-infectious vaccines and drugs trials; and of several studies on clinical, epidemiology and immunology of helminth, Tuberculosis and malaria co-infection in school children and pregnant women in collaboration with the Leiden Medical University Center in Leiden (LUMC) and the University of Tübingen (UKT). He is co-supervising medical and bio-medical students from UKT, LUMC, Medical University of Libreville, the University of Sciences and Technology of Franceville and the Ecole Doctorale Régionale de Franceville for their Master’s, medical doctorate and PhD thesis. He is a regular visiting scientist at the Medical University of Leiden in The Netherlands.
Dr Anthony Man
by registration only
Foyer 2
Tony Man is the Therapeutic Area Head of Anti-Infectives at the Novartis Global Health Development Unit, Basel, Switzerland.
Tony qualified in Biochemistry and Medicine in the United Kingdom in 1979 then undertook his postgraduate training in Internal Medicine and Medical Oncology. After 7 years in academic medicine he pursued a career in clinical research within the Pharmaceutical Industry where he has led and contributed to over 20 successful new drug development programmes.
Dr. Man has spent 17 years in large pharma companies in a variety of Global Scientific and Development roles including Global Head of Oncology at Hoffmann La Roche, Head of Clinical Pharmacology and Translational Medicine (Oncology Business Unit) and Global Development Head for Greater China. In addition, he spent 13 years in the Biotechnology Industry as Chief Medical Officer and subsequently CEO of a public Biotech company (Basilea Pharmaceutica AG) until 2013.
He teaches different aspects of Pharmaceutical Medicine on the faculties of the European Course on Pharmaceutical Medicine (ECPM) and Chinese Course of Drug Regulatory Science (CCDRS). Tony currently serves as R&D Technical Adviser to EDCTP.
Dirk Gillé
by registration only
Foyer 2
Dirk Gillé, VP – R&D Fellowship Development Leader – Global Public Health
Dirk has more than 30 years of experience in drug development. Amongst other Dirk was Clinical & Compound development team member in the dermatology franchise at the Janssen Research Foundation. Later he has set up the medical departments in Central & Eastern Europe from a Pharmacovigilance and Clinical Development perspective, integrating the region in the development organization. In 1999, Dirk left J&J and joined Tibotec as Senior Director of Global Clinical Operations, creating a worldwide structure for Clinical Operations and Quality Management. After Tibotec was acquired by J&J, he drove the development of the New Operating Model for the newly created GCO organization. In 2009, Dirk became the Global Head of Quality Management & Training, responsible for implementing a clinical QMS that created efficiencies and enhanced compliance in the clinical arena for the newly created Janssen R&D organization. In 2012 he became Global Head of the Janssen R&D Quality Assurance organization, responsible for the audit programs in the non-regulated, GLP, GCP and PV domains.
Since Oct 2017, Dirk joined J&J R&D Global Public Health as R&D Fellowship Development Leader, responsible for capacity building initiatives that should facilitate the execution of the R&D GPH programs and support capacity building in resource limited settings.
Dirk has two Master’s degrees, both from Catholic University of Leuven; one in Physical Education and one in Physiotherapy. He also has two post-graduate degrees, one in Dermato-cosmetic Sciences and one in Business Management. He is ISO 31000 Risk Management certified. Dirk is based in Beerse, Belgium.
Dr Godfrey Biemba
by registration only
Foyer 2
Dr. Godfrey Biemba is Director and Chief Executive Officer of the National Health Research Authority (NHRA) in Zambia. The NHRA is a statutory body responsible for regulating and promoting all health related research in Zambia, which includes registering and accrediting researchers, research institutions and research ethics committees or institutional review boards. He is also Adjunct Research Assistant Professor of Global Health at Boston University School of Public Health. Before his appointment as NHRA CEO, Dr. Biemba was a Research Assistant Professor of Global Health at Boston University School of Public Health (BUSPH) from 2008 to 2017 and Country Director of the Zambian Center for Applied Health Research and Development (ZCAHRD) Limited from 2010 to 2017.
Dr. Biemba has 33 years’ experience in the health sector as a medical practitioner, researcher, and public health manager. The focus of his past 28 years has been conducting various types of health related research, ranging from clinical trials to community based evaluations, impact evaluations of public health programmes, situational analyses in the areas of malaria, health systems, orphans and vulnerable children, water, sanitation and hygiene (WASH), road safety, maternal, neonatal, and child health, and HIV/AIDS. His public health research has involved the use of various quantitative and qualitative research methods. In addition to conducting his own research, Dr. Biemba has spent a lot of time building research capacity through teaching and mentorship of young scientists conducting clinical trials, community based trials, including cluster randomised trials, health systems research and good clinical practice (GCP) in the conduct of research. He has been a clinical trials study monitor and has sat on data safety monitoring boards (DSMB).
Dr Jutta Reinhardt-Rupp
by registration only
Foyer 2
Dr Jutta Reinhard-Rupp is Head of the Research and Development Translational Innovation Platform for ‘Global Health’ at Merck Serono. Her focus is the discovery and development of new drugs and health solutions for children suffering from poverty-related diseases, such as malaria and schistosomiasis. Jutta Reinhard-Rupp studied biology in Mainz and Tübingen and received her PhD at the Max-Planck Institute in Tübingen. After her postdoctoral training at Novartis, she was head of laboratory at Evotec Biosystems in Hamburg. In 1997, she joined Aventis in various assignments in R&D. Since January 2008, she works with Merck Serono in Switzerland with main responsibilities on the implementation of key strategic initiatives in drug discovery and development, including the lead of several ‘Global Health’ programmes. The current flagship programme is the development of a new paediatric formulation of praziquantel to treat young children in schistosomiasis endemic areas.
Professor Maria Rosário Oliveira Martins
by registration only
Foyer 2
Professor Maria Fraga Oliveira Martins is Professor of Biostatistics at the New University of Lisbon (UNL), Institute of Hygiene and Tropical Medicine, Portugal. She also holds the positions of member of the General Council of the UNL and member of the Ethics Committee for Clinical Research (CEIC), Ministry of Health of Portugal. She completed a Bachelor’s degree in Economics at UNL (1986), and has a Masters and PhD in Econometrics from the Université Libre de Bruxelles (1994, 1999). Her research interests include biostatistics, health economics, econometrics, ethics and statistical modelling of tropical diseases. She has a focus on research capacity strengthening and training in Portuguese-speaking African countries.
Dr Maryline Bonnet
by registration only
Foyer 2
Dr Maryline Bonnet is Research Director at the Institute of Research for Development (IRD) in Montpellier, France, since December 2013. Following her medical degree (1992) and a Master’s degree in Physiology and Parasitology (1993) at the University of Grenoble, she worked for Médecins Sans Frontières (MSF) from 1994-2003. During this time, she was based in various countries, including Benin, Vietnam and the former Russian states, where she managed MSF tuberculosis programmes. From 2003 she worked at Epicentre, Geneva, as an epidemiologist and completed a doctorate in public health at the Pierre and Marie Curie University, Paris, in 2009. She took up her post as Research Director at IRD in December 2013. Dr Bonnet is a clinical epidemiologist with considerable experience in the clinical management of tuberculosis and the management and evaluation of tuberculosis control programmes. Moreover, she has served on several review and advisory boards of the ANRS and WHO.
Dr Mohammed Lamorde
by registration only
Foyer 2
Mohammed Lamorde is Head of Department of Prevention, Care and Treatment at the Infectious Diseases Institute (IDI), Makerere University, Uganda. He is the Director of the Global Health Security Partner Engagement Project. Funded by the United States Centers for Disease Control and Prevention, the project aims to accelerate Uganda’s progress towards achieving the Global Health Security Agenda targets to prevent, detect and respond to infectious diseases outbreaks and other biologic threats. Dr. Lamorde’s training as a clinical pharmacologist and physician serve as the foundation for his research, which since 2007 has focused on developing capacity in clinical pharmacology relevant to Global Health in Uganda. In 2012, he was awarded a doctorate degree from Trinity College Dublin in 2012 focusing on the clinical pharmacokinetics of HIV drugs. He was elected as a Fellow of the Royal College of Physicians (London) in 2017. Since 2015, he has overseen clinical services at the IDI including the Adult Infectious Diseases Clinic at Mulago where 7,500 patients with HIV receive clinical services.
Dr Lamorde is Project Director of the CAPA-CT project (Enhancing Capacity for Phase 1 trials for Ebola and other Viral Hemorrhagic Fevers in Uganda) funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Special Programme for Research and Training in Tropical Diseases (WHO/TDR). Dr Lamorde is co-investigator on the Joint Mobile Emerging Diseases Intervention Clinical Capabilities consortium which aims to conduct clinical trials on investigational new drugs during filovirus outbreaks.
Professor Peter Smith
by registration only
Foyer 2
Peter Smith is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM). He graduated in mathematics and statistics from City University, London, and in 1965 joined the Medical Research Council’s Statistical Research Unit in London. Since then he has worked on various aspects of epidemiological and statistical research in the MRC Clinical and Population Cytogenetics Research Unit, Edinburgh (1967-69); Makerere University Medical School, Uganda (1970-71); the International Agency for Research on Cancer, Lyon, France, and Uganda (1971-72); the Imperial Cancer Research Fund Cancer Epidemiology Unit, Oxford (1972-79); Harvard School of Public Health, Boston (1987); and the Tropical Diseases Research Programme of WHO (1987). He joined LSHTM in 1979 to head the Tropical Epidemiology Unit and headed the Department of Epidemiology and Population Sciences from 1990-96 and the newly created Department of Infectious and Tropical Diseases from 1997 to 2004.
His research interests include large-scale intervention studies against tropical diseases, including vaccine trials. He was involved in research on the link between Bovine Spongiform Encephalopathy (BSE) and Creutzfeldt-Jakob Disease in humans. Up to 2011, he chaired the WHO Global Advisory Committee on Vaccine Safety and chairs the WHO Global Malaria Programme/Initiative for Vaccine Research Joint Technical Expert Group (JTEG) on Malaria Vaccines in Pivotal Phase 3 Trials and beyond. He has served on the Scientific Advisory Board of the International Vaccine Institute in Korea and the Board of Management of the Medicines for Malaria Venture. He currently chairs the Programme Board for Global Health and Vaccination Research (GLOBVAC) of the Research Council of Norway. He has served as the Deputy Chair of the Nuffield Council on Bioethics and from 2004 to 2014 was a Governor of the Wellcome Trust. He also was a member of the Board of Directors of PATH.
Professor Quarraisha Abdool Karim
by registration only
Foyer 2
Professor Quarraisha Abdool Karim is an NRF A-rated scientist, infectious diseases epidemiologist and Associate Scientific Director of CAPRISA. Her research for the past 28 years has focused on HIV infection in adolescent girls and young women. This includes the conduct of clinical trials from early phase, through proof of concept and implementation of new discoveries. She has been actively involved in the NIH funded treatment and prevention networks. She was co-chair of the HIV Prevention Trials Network (HPTN) from 2006 to 2012 and continues to be involved at a leadership level. She was the PI of the Columbia University - Southern African Fogarty AIDS International Training and Research Programme (CU-SA Fogarty AITRP) that focused on establishing a strong science base and increasing the capacity to conduct clinical RCTs to highest international scientific and ethical standards. She is Professor in Clinical Epidemiology at the Mailman School of Public Health, Columbia University, USA and is Pro-Vice Chancellor for African Health at the University of KwaZulu-Natal in South Africa. Abdool Karim is the UNAIDS Special Ambassador for Adolescents and HIV, a member of the UNAIDS Scientific Expert Panel and Scientific Advisor to the Executive Director of UNAIDS, Scientific Advisory Board member of the US President’s Emergency Plan for AIDS Relief (PEPFAR), member of the MACAIDS Foundation Board; Deputy-Chair of the Board of the South African Medical Research Council where she also chairs the Research and Development Committee.
Dr Roma Chilengi
by registration only
Foyer 2
Dr Chilengi is a Zambian physician, epidemiologist and vaccinologist currently employed as Chief Scientific Officer at the Centre for Infectious Disease Research (CIDRZ) in Zambia. In his current role, he oversees all research programmes, leads several research studies as well as health systems strengthening programmes. Having primarily worked on vaccine preventable infectious disease research for the past 18 years, his interests have shifted to also include non-communicable diseases in the last few years. He is conducting ongoing research in enteric disease and working on several vaccine studies including rotavirus, ETEC, Shigella, as well as HIV. He was awarded an R01 IRIDA grant 1R01AI099605, which evaluated potential causes of rotavirus vaccine failure in Zambian infants, and presently holds a Senior Fellowship Award from the European & Developing Countries Clinical Trials Partnership (EDCTP) studying rotavirus vaccine immunogenicity. Presently he is also leading efforts towards establishing Human Infection Challenge studies in Zambia.
Mrs Virginie Pirard
by registration only
Foyer 2
Virginie Pirard, born in Brussels (Belgium, 1975), is a jurist and philosopher, specialized in Ethics, Bioethics and Research Ethics.
After a grant as Research Fellow (FNRS) in moral philosophy which gave her the opportunity to work on care ethics and vulnerabilities (Centre for Political Theory, Free University of Brussels), she served several years as counsellor and expert on Bioethics and Health related societal issues (including equity and gender mainstreaming) at the Cabinet of Vice Prime Minister and Minister of Public Health in Belgium. Since 2012, she’s working at Institut Pasteur (Paris, France), where she heads the Ethics Unit and developed a comprehensive experience on ethics issues such as participants and vulnerable population advocacy, benefit sharing, risk/benefit assessment, genomic data sharing, ethics and outbreak. As Chair of an Institutional Review Board during 6 years (2012 -2018), she has a strong experience and commitment creating and fostering a culture of integrity, transparency and independence among the Boards’ Members, as well as she is highly attentive and well-informed on ethical issues related to the funding, implementation and monitoring of research projects. She also regularly provides training and lectures in Ethics to Health professionals, researchers and young students.
She is a Member of the Belgium’s Advisory Committee on bioethics since 2009. She is currently the Coordinator of the Grant AFREENET (2018-2021), a 3-year EDCTP funded project aiming to support and reinforce the activities of three National Ethics Committees (NECs) located in West Africa : in Côte d’Ivoire, Guinea and Benin.
13:00
13:45
E-Poster Presentations
E-poster Presentation
Sala / Room 1
Monitor 1: HIV
E-poster Presentation
Sala / Room 1
Ndlovu, Nokuthula S.
PO - (8411) - MOLECULAR CHARACTERIZATION OF GP41 AND GP120 V3 LOOP IN HIV 1C PATIENTS FAILING SALVAGE THERAPY IN BOTSWANA
Ndlovu, Nokuthula S. (Zimbabwe)1; Seatla, Kaelo (Botswana)2
1 - Midlands State University Zimbabwe, Botswana Harvard Partnership; 2 - Botswana Harvard Partnership, University of Botswana
Kivuyo, Sokoine
PO - (8447) - ROBUST CLINICAL TRIALS ARE NOT ENOUGH: OVERCOMING OPERATIONAL CHALLENGES FOR IMPLEMENTING REMSTART INTERVENTION PACKAGE (TRIP STUDY) INTO ROUTINE PRACTICE.
Kivuyo, Sokoine (Tanzania)1; Erick, Frank (Tanzania)1; Loyse, Angela (United Kingdom)2; Jaffar, Shabbar (United Kingdom)3; Mfinanga, Gofrey (Tanzania)1
1 - National Institute For Medical Research-Muhimbili Centre; 2 - ST Georges University of London; 3 - Liverpool School of Tropical Medicine
Ngowi, Kennedy M
PO - (8480) - TECHNICAL FEASIBILITY OF SENDING SMS TO REMIND TAKING MEDICATION AMONG PREGNANT AND BREASTFEEDING WOMEN LIVING WITH HIV IN KILIMANJARO, TANZANIA
Ngowi, Kennedy M (Tanzania)1; Maro, Eusebious (Tanzania)2; Nieuwkerk, Pythia T (Netherlands)3; Maro, Rob E (Netherlands)4; Mmbaga, Blandina T (Tanzania)1,2; Sumari-De Boer, I Marion (Tanzania)1,5
1 - Kilimanjaro Clinical Research Institute, Moshi, Tanzania; 2 - Kilimanjaro Christian Medical Center, Moshi, Tanzania; 3 - Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands; 4 - Department of Pharmacy and with the Radboud Institute for Health Sciences, RadboudUMC, Nijmegen, the Netherlands; 5 - Department of International Health, RadboudUMC, Nijmegen, the Netherlands
Wanjiru, Rodah
PO - (8483) - ASSOCIATIONS BETWEEN HIV AND OTHER STIS AMONG GAY, BISEXUAL MEN AND TRANSGENDER WOMEN IN NAIROBI, KENYA
Wanjiru, Rodah (Kenya)1; Kimani, Joshua (Kenya)2; Smith, Adrian (United Kingdom)3
1 - Partners for Health and Development; 2 - 1Partners for Health and Development; 3 - University of Oxford, Nuffield Department of Population Health, Old Road Campus, Oxford OX3 7LF
Kilembe, William
PO - (8515) - CAPACITY BUILDING IN PREPARATION FOR HIV VACCINE TRIAL: GLOBALLY RELEVANT AIDS VACCINE EUROPE-AFRICA TRIALS PARTNERSHIP (GREAT)
Kilembe, William (Zambia)1; Okech, Brenda (Uganda)2; Nielsen, Leslie (Uganda)3; Muturi-Kioi, Vincent (Kenya)3; Jaoko, Walter (Kenya)4; Mutua, Gaudensia (Kenya)4; Sanders, Eduard (Kenya)5; Mpendo, Juliet (Uganda)2; Gumbe, Anne (Kenya)3; Chinyenzi, Kundai (Kenya)3; De Bont, Jan (Uganda)3; Kuipers, Hester (Netherlands)3; Crook, Alison (United Kingdom)8; King, Deborah (United Kingdom)6; Kaleebu, Pontiano (Uganda)7; Fast, Patricia (United States of America)3; Hanke, Tomas (United Kingdom)8
1 - Zambia Emory HIV Research Project; 2 - Uganda Virus Research Institute - International AIDS Vaccine Initiative; 3 - International AIDS Vaccine Inititative; 4 - University of Nairobi; 5 - Kenya Medical Research Institute; 6 - International AIDS Vaccine Initiative - Human Immunology Laboratory; 7 - Medical Research Council - Uganda Virus Research Institute; 8 - University of Oxford
Akolo, Maureen
PO - (8549) - ACHIEVING THIRD 90 AMONG KEY POPULATION-THROUGH DIFFERENTIATED CARE MODEL
Akolo, Maureen (Kenya)1; Kimani, Joshua (Kenya)2; Gelmon, Larry (Kenya)2
1 - PHDA; 2 - University of Nairobi/Manitoba
S.Kibiki, Gibson
PO - (8569) - INNOVATIVE DOMESTIC FINANCING FOR HEALTH RESEARCH AND DEVELOPMENT IN THE EAST AFRICAN COMMUNITY
Ngirabega, Jean De Dieu (Burundi)1; Twungubumwe, Novat (Burundi)1; K.Pulakkal, Nandanan (Uganda)2; N. Bahati, Prince (Kenya)3; Kamali, Anatoli (Kenya)3; S.Kibiki, Gibson (Burundi)1
1 - East African Health Research Commission; 2 - Future Options Consulting Ltd; 3 - International AIDS Vaccine Initiative
Silva, Bruno
PO - (8578) - THE ROLE OF CLINICAL RESEARCH IN EDUCATING THE HEALTH WORKFORCE IN GUINEA-BISSAU
Silva, Bruno (Guinea-Bissau)1
1 - Bandim Health Project
Monitor 2: Neglected infectious diseases
E-poster Presentation
Sala / Room 1
Haile, Filimon Mitiku
PO - (8409) - SERUM HYALURONIC ACID: A POTENTIAL DIAGNOSTIC MARKER FOR SCHISTOSOMAL PERIPORTAL FIBROSIS IN SCHISTOSOMA MANSONI ENDEMIC AREAS.
Haile, Filimon Mitiku (Ethiopia)1; Hagos, Elsa (Ethiopia)2; Berhe, Nega (Ethiopia)1; Myrvang, Bjørn (Norway)3; Gunderse, Svein G (Norway)4
1 - Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia; 2 - Semera University, Semera, Ethiopia; 3 - Institute for International Health, University of Oslo, Oslo, Norway; 4 - Sorlandet Hospital HF and Agder University College, Kristiansand, Norway
Ngay, Lukusa
PO - (8421) - LITERATURE REVIEW OF BIOMARKERS FOR HUMAN AFRICAN TRYPANOSOMIASIS POST-TREATMENT FOLLOW-UP
Ngay, Lukusa (Congo (the Democratic Republic of the))1; Veerle, Lejon (France)2; Ngoyi, Mumba (Congo (the Democratic Republic of the))1
1 - Institut National de Recherche Biomedicale (INRB); 2 - Institut de Recherche pour le developpement (IRD)/Montpellier
Boshara, Salah
PO - (8425) - THE DIAGNOSTIC AND PROGNOSTIC VALUE OF NEW URINE BASED LEISHMANIA ANTIGEN DETECTION TESTS
Boshara, Salah (Sudan)1
1 - Institute of Endemic Diseases-University of Khartoum
Kaboré, Jacques
PO - (8441) - EXPERIMENTAL COMPARISON OF SENSITIVITY OF LAMP AND REAL TIME PCR
Kaboré, Jacques (Burkina Faso)1; Ilboudo, Hamidou (Guinea)2; Compaoré, Charlie Franck Alfred (Burkina Faso)1; Camara, Ooumou (Guinea)2; Bamba, Mohamed (Burkina Faso)1; Sakandé, Hassane (Burkina Faso)1; Camara, Mamadou (Guinea)2; Bucheton, Bruno (Guinea)2; Kaba, Dramane (Côte d'Ivoire)3; Jamonneau, Vincent (Côte d'Ivoire)3; Deborggraeve, Stijn (Belgium)4; Lejon, Veerle (France)5
1 - Centre International de Recherche-Développement sur l’Elevage en zone Subhumide (CIRDES/UNB); 2 - Programme National de Lutte contre la THA; 3 - Institut Pierre Richet; 4 - Institut de Médecine Tropicale; 5 - Institut de Recherche pour le Developpement
Camara, Oumou
PO - (8473) - IMPACT OF EBOLA ON SLEEPING SICKNESS IN COASTAL GUINEA: A RETROSPECTIVE ANALYSIS (2012-2017) FROM THE GUINEAN NATIONAL CONTROL PROGRAM
Camara, Oumou (Guinea)2; Ilboudo, Hamidou (Guinea)1,2; Camara, Mariame (Guinea)2; Ouattara, Eric (France)3; Duvignaud, Alexandre (France)3; Leno, Mamadou (Guinea)2; Solano, Philippe (France)1; Malvy, Denis (France)3; Bucheton, Bruno (France)1; Camara, Mamadou (Guinea)2
1 - UMR 177 IRD-CIRAD INTERTRYP, Institut de Recherche pour le Développement, Montpellier, France; 2 - Programme National de Lutte contre la Trypanosomiase Humaine Africaine PNLTHA-Ministère de la Santé, Conakry, République de Guinée; 3 - Department of Tropical Medicine and Clinical International Health, CHU Bordeaux, Bordeaux, France
Edoa, Jean-Ronald
PO - (8503) - EPIDEMIOLOGY, CO-INFECTIONS AND HAEMATOLOGICAL FEATURES OF SCHISTOSOMIASIS IN SCHOOL AGED CHILDREN LIVING LAMBARÉNÉ, GABON
Dejon Agobe, Jean Claude (Gabon)1; Honkpehedji, Yabo Josiane (Gabon)1; Zinsou, Jeannot Fréjus (Gabon)1; Edoa, Jean-Ronald (Gabon)1; Adegbite, Bayodé Roméo (Gabon)1; Duali, Mohamed (Gabon)1; Mougeni, Fabrice Lotola (Gabon)1; Lell, Bertrand (Gabon)1; Kremsner, Peter Gottfried (Germany)2; Grobusch, Martin Peter (Netherlands)3; Adegnika, Ayola Akim (Gabon)1
1 - Centre de Recherches Médicales de Lambaréné (CERMEL); 2 - Institut für Tropenmedizin, Eberhad Karls Universität Tübingen and German Center for Infection Research (DZIF); 3 - Academic Medical Center, University of Amsterdam
Cortes, Sofia
PO - (8505) - LEISHMANIASIS IN ANGOLA- AN EMERGING DISEASE?
Cortes, Sofia (Portugal)1; Pereira, André (Portugal)1; Vasconcelos, Jocelyne (Angola)2; Paixão, Joana Paula (Angola)2; Quivinja, Joltim (Angola)2; Afonso, Joana De Morais (Angola)2; Cristóvão, José Manuel (Portugal)1; Campino, Lenea (Portugal)1
1 - Global Health and Tropical Medicine Center, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa; 2 - Instituto Nacional de Saúde Pública (INSP), Ministério da Saúde de Angola
Lejon, Veerle
PO - (8567) - ASSOCIATION ENTRE LE POLYMORPHISME RS 73885319 DU GÈNE APOL1ET LA RESISTANCE /SUSCEPTIBILITÉ
Miaka Erick, Mwamba (Congo (the Democratic Republic of the))1; Lejon, Veerle (France)2; Ilboudou, Hamidou (Burkina Faso)3
1 - Veerle lejon and Hamidou ilboudo; 2 - Institu de développement et de recherche; 3 - Phillippe solano
Monitor 3: Emerging diseases and data sharing
E-poster Presentation
Sala / Room 1
Adekeye, Joshua
PO - (8313) - PREDICTORS OF HEALTH INSTITUTIONAL READINESS FOR EBOLA EPIDEMIC CONTAINMENT IN NIGERIA:A STRUCTURAL EQUATION MODELLING(SEM) APPROACH
Adekeye, Joshua (South Africa)1; Eustasius, Musenge (South Africa)1; Arulogun, Oyedunni (Nigeria)2
1 - University of the Witwatersrand; 2 - University of Ibadan
Ntoumi, Francine
PO - (8460) - PANDORA-ID NET (PAN-AFRICAN NETWORK FOR RAPID RESEARCH, RESPONSE, RELIEF AND PREPAREDNESS FOR INFECTIOUS DISEASES EPIDEMICS)
Ntoumi, Francine (Congo)1; Zumla, Francine (United Kingdom)2; Ippolito, Giuseppe (Italy)3; Vairo, Francesco (Italy)3
1 - Fondation Congolaise pour la Recherche Médicale; 2 - University College of London; 3 - National Institute for Infectious diseases LazzaroSpallanzani
Kisakye, Jacqueline
PO - (8470) - FIRST INDEPENDENT ASSESSMENT OF PHARMACEUTICAL COMPANY ACTION ON AMR
Kisakye, Jacqueline (Netherlands)1; Knoeff, Josefien (Netherlands)1; Ruiz, Adrian (Netherlands)1; Calcada, Dulce (Netherlands)1; Iyer, Jayasree (Netherlands)1; Breugelmans, J. Gabrielle (Netherlands)1
1 - Access to Medicine Foundation
Landuyt, Hanne
PO - (8471) - A SURVEY ON CURRENT CLINICAL DATA MANAGEMENT PRACTICES IN SUB-SAHARAN AFRICA
Landuyt, Hanne (Belgium)1; Van Loen, Harry (Belgium)1; Dondeh, Bai Lamin (Gambia)2; Gaye, Badou M. (Gambia)2; Van Herrewege, Yven (Belgium)1
1 - Institute of Tropical Medicine Antwerp; 2 - Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine
Van Loen, Harry
PO - (8490) - PROMOTING GOOD DATA MANAGEMENT PRACTICES IN CLINICAL RESEARCH IN RESOURCE-POOR SETTINGS
Van Loen, Harry (Belgium)1; Arango, Diana (Belgium)1; Landuyt, Hanne (Belgium)1; Burm, Christophe (Belgium)1; Van Herrewege, Yven (Belgium)1
1 - Institute of Tropical Medicine Antwerp
Van Loen, Harry
PO - (8495) - DATA SHARING IS PART OF DATA MANAGEMENT: THE NEED FOR A HOLISTIC AND COHERENT VIEW ON RESEARCH DATA MANAGEMENT.
Van Loen, Harry (Belgium)1; Thiongo, Mary (Kenya)2; Van Herrewege, Yven (Belgium)1
1 - Institute of Tropical Medicine Antwerp; 2 - International Centre for Reproductive Health Kenya
Cherif, Mahamoud Sama
PO - (8522) - ESTABLISHING AN EQUITABLE GOVERNANCE FRAMEWORK FOR AN EBOLA DATA-SHARING PLATFORM
Cherif, Mahamoud Sama (Guinea)1; Craig, Elaine (United Kingdom)1; Strudwick, Samantha (United Kingdom)1; Hawryszkiewycz, Alice (United Kingdom)1; Merson, Laura (United Kingdom)1
1 - Gamal Abdel Nasser University of Conakry, Guinea and Infectious Diseases Data observatory, University of Oxford, UK
Bache, Emmanuel Bache
PO - (8581) - ZOONOTIC VIRAL ANTIGENS SURVEILLANCE IN HEALTHY POPULATIONS LIVING IN LAMBARÉNÉ, GABON
Bache, Emmanuel Bache (Gabon)1; Loembe, Marguerite Massinga (Gabon)1,2; Agnandji, Selidji Todagbe (Gabon)1,2
1 - Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; 2 - Institut für Tropenmedizin, Universitätsklinikum Tübingen, Germany
Araújo, Isabel Inês
PO - (8608) - ESTABLISHED PARTNERSHIPS BETWEEN UNIVERSITY OF CAPE VERDE, UNIVERSITY OF LEICESTER - UK OR THE INSTITUTE OF HYGIENE AND TROPICAL MEDICINE,PORTUGAL
Araújo, Isabel Inês (Cape Verde)1; Beleza, Sandra (United Kingdom)2; Martins, Maria Do Rosário (Portugal)3
1 - Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde; 2 - Department of Genetics and Genome Biology, University of Leicester; 3 - Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa
13:00
13:45
E-Poster Presentations
E-poster Presentation
Sala / Room 2
Monitor 1: Malaria
E-poster Presentation
Sala / Room 2
Arroz, Jorge
PO - (7151) - COMPARING TWO BED NETS DELIVERY MODELS IN RURAL DISTRICTS OF MOZAMBIQUE
Arroz, Jorge (Mozambique)1
1 - Mozambique medical council
Habonimana, Desire
PO - (7167) - IMPROVING LONG-LASTING INSECTICIDAL NETS USE IN KAYANGE COMMUNITY OF NORTH-WESTERN BURUNDI: A QUALITY IMPROVEMENT STUDY
Habonimana, Desire (Burundi)1; Ndayisaba, Gabriel (Burundi)1; Nimako, Gideon (South Africa)2
1 - University of Burundi; 2 - University of the Witwatersrand
Anaba, Michael
PO - (8248) - DETERMINANTS OF ACCEPTABILITY OF MALARIA RAPID DIAGNOSTIC TEST AMONG HEALTH WORKERS IN KINTAMPO NORTH MUNICIPALITY, GHANA
Anaba, Michael (Ghana)1; Ae-Ngebisi, Kenneth (Ghana)1; Owusu Agyei, Seth (Ghana)2; Ibisomi, Latifat (South Africa)3
1 - Kintampo Health Research Center; 2 - University of Health & Allied Sciences; 3 - University of Witwatersrand
Barry, Nourou
PO - (8264) - ‘‘QUALITY CARE’’ CRITERIA IN A CLINICAL TRIAL CONTEXT: PATIENTS AND DAFRA AND NANORO CMA HEALTH WORKERS’ PERCEPTIONS (BURKINA FASO)
Barry, Nourou (Burkina Faso)1; Pare/Toe, Léa (Burkina Faso)1; Toe, Patrice (Burkina Faso)2
1 - Institut de Recherche en Sciences de la Santé / Centre Muraz; 2 - Nazi Boni University of Bobo-Dioulasso
Mwesigwa, Julia
PO - (8302) - IMPACT OF TWO ANNUAL ROUNDS OF MASS DRUG ADMINISTRATION WITH DIHYDROARTEMISININ-PIPERAQUINE ON MALARIA TRANSMISSION IN A PROSPECTIVE COHORT STUDY
Mwesigwa, Julia (Gambia)2; Achan, Jane (Gambia)2; Wathou, Miriam (Gambia)2; Worwui, Archibald (Gambia)2; Mohammed, Nuredin (Gambia)2; Kanuteh, Fatoumatta (Gambia)2; Van Greetruyden, Jean-Pierre (Belgium)1; D'alessandro, Umberto (Gambia)2
1 - Faculty of Medicine and Health Sciences, University of Antwerp; 2 - MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine
Ajumobi, Olufemi
PO - (8422) - AN INNOVATIVE APPROACH TO DEVELOPING A NATIONAL MALARIA OPERATIONS RESEARCH AGENDA - NIGERIAN EXPERIENCE
Ajumobi, Olufemi (Nigeria)1; Ajayi, Ikeoluwapo (Nigeria)2; Nguku, Patrick (Nigeria)3
1 - AFENET Nigeria; 2 - University of Ibadan, Nigeria; 3 - AFENET
Gondwe, Thandile
PO - (8426) - DELIVERY OF POST-DISCHARGE MALARIA CHEMOPREVENTION (PMC) WITH DIHYDROARTEMESININ-PIPERAQUINE FOR MANAGEMENT OF CHILDREN WITH SEVERE ANAEMIA IN MALAWI
Gondwe, Thandile (Malawi)1; Robberstad, Bjarne (Norway)2; Mukaka, Mavuto (United Kingdom)1; Blomberg, Bjorn (Norway)2; Phiri, Kamija (Malawi)1
1 - University Of Malawi; 2 - University Of Bergen
Masumbe Netongo, Palmer
PO - (8574) - LESSONS FROM ENGAGING AND TRAINING PRIVATE AND FAITH-BASED HEALTH FACILITIES FOR THE USE OF MALARIA RAPID DIAGNOSTIC TESTS IN CAMEROON.
Masumbe Netongo, Palmer (Cameroon)1,2,3; Irenee, Domkam (Cameroon)1,3,5; Kamdem, Séverin Donald (Cameroon)1,3; Maloba, Franklin (Cameroon)1,3; Nji, Akindeh (Cameroon)1,2; Tchoupe, Eric (Cameroon)1,3; Bidias, Amel (Cameroon)3; Namboh, Becky (Cameroon)3; Kwedi-Nolna, Sylvie (Cameroon)3,6; Athogo-Tiedeu, Barbara (Cameroon)2,3; Dacombe, Russell (United Kingdom)4; Mbacham, Wilfred (Cameroon)2,3
1 - Molecular Diagnosis Research Group, Biotechnology Centre-University of Yaounde I (BTC-UY-I), Cameroon; 2 - Department of Biochemistry, Faculty of Science, University of Yaounde I (UY1), Cameroon; 3 - Initiative to Strengthen Health Research Capacity in Africa (ISHReCA), Biotechnology Centre-University of Yaounde I (BTC-UY-I); 4 - Liverpool School of Tropical Medicine, UK.; 5 - Centre International de recherche et de Référence "Chantal Biya" (CIRCB); 6 - 5Faculty of Medecine and Biomedical Sciences University of Yaounde I, Cameroon
Monitor 2: Tuberculosis
E-poster Presentation
Sala / Room 2
Dockrell, Hazel
PO - (8394) - SOUTH-SOUTH AND NORTH-SOUTH CAPACITY STRENGTHENING WITHIN THE SCREENTB CONSORTIUM: WHAT HAVE WE LEARNT?
Dockrell, Hazel (United Kingdom)1; Schacht, Claudia (Germany)2; Walzl, Gerhard (South Africa)3
1 - London School of Hygiene & Tropical Medicine; 2 - LINQ management GmbH; 3 - Stellenbosch University
Mogashoa, Tuelo
PO - (8408) - DETECTION OF EXTENSIVELY DRUG RESISTANT TUBERCULOSIS AMONG MULTI-DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES IN BOTSWANA
Mogashoa, Tuelo (Botswana)1,2; Mupfumi, Lucy (Botswana)1,2; Iketleng, Thato (Botswana)2,3; Melamu, Pinkie (Botswana)2; Kelentse, Nametso (Botswana)2; Zetola, Nicola (Botswana)4; Mokomane, Margaret (Botswana)5; Letsibogo, Letsibogo (Botswana)5; Streicher, Elizabeth Maria (South Africa)6; Ley, Serej (South Africa)6; Kasvosve, Ishmael (Botswana)1; Moyo, Sikhulile (Botswana)1,2,7; Warren, Robin (South Africa)6; Gaseitsiwe, Simani (Botswana)2,7
1 - Department of Medical Laboratory Sciences, University of Botswana, Gaborone, Botswana,; 2 - Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; 3 - College of Health Sciences, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; 4 - Botswana Upenn Partnership, Gaborone Botswana; 5 - National Tuberculosis Reference Laboratory, Ministry of Health and Wellness, Gaborone, Botswana; 6 - DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; 7 - Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Ngari, Moses
PO - (8417) - RISING TRENDS IN TB MORTALITY AMID DECLINE IN CASES NOTIFIED IN A RURAL COUNTY IN KENYA: COHORT STUDY
Ngari, Moses (Kenya)2; Abdullahi, Osman (Kenya)1; Sanga, Deche (Kenya)3; Katana, Geoffrey (Kenya)4; Willetts, Annie (Kenya)1
1 - Pwani University, Department of Public Health, Kilifi, Kenya; 2 - KEMRI Wellcome Trust Research Programme, Kilifi; 3 - Kilifi County TB Control Program, Kilifi, Kenya; 4 - Kilifi County Department of Public Health, Kilifi, Kenya
Wandiga, Steve
PO - (8446) - COLLABORATIVE TUBERCULOSIS RESEARCH AGENDA AT KEMRI CENTER FOR GLOBAL HEALTH RESEARCH, KISUMU, KENYA.
Wandiga, Steve (Kenya)1; Agaya, Janet (Kenya)1; Gurrion Ouma, Samuel (Kenya)1; Ochieng Okumu, Albert (Kenya)1; Kiringa, Grace (Kenya)2; Otieno, Juliana (Kenya)3; Mwai, Geoffrey (Kenya)4; Nduba, Videlis (Kenya)2; Munga, Stephen (Kenya)1
1 - Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya; 2 - Kenya Medical Research Institute - Center for Respiratory Diseases Research; 3 - Jaramogi Oginga Odinga Teaching and Referral Hospital; 4 - Siaya County Referral Hospital
Ngadaya, Esther
PO - (8504) - EFFECT OF INCREASE USER FEES IN ACCESSING NEW TUBERCULOSIS DIAGNOSTIC SERVICES IN TANZANIA
Ngadaya, Esther (Tanzania)1; Kimaro, Godfather (Tanzania)1; Shemtandulo, Ramadhani (Tanzania)1; Sandi, Erica (Tanzania)1; Simsokwe, Sunday (Tanzania)2; Nguma, Oliva (Tanzania)2; Kibwana, Omari (Tanzania)3; Mgina, Nicholaus (Tanzania)4; Mfinanga, Godfrey Sayoki (Tanzania)1
1 - National Institute for Medical Research, Muhimbili Research Centre; 2 - Sumbawanga regional hospital; 3 - Mnazi Mmoja Hospital Zanzibar; 4 - Musoma Regional Hospital
Diarra, Bassirou
PO - (8544) - USE OF XPERT MTB/RIF AND FDA MICROSCOPY RELATIVE TO MONTHLY CULTURES IN MONITORING MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN BAMAKO, MALI
Diarra, Bassirou (Mali)1,7; , Aissata B (Mali)2; Decroo, Tom (Belgium)3; Keita, Marie L (Mali)1; Degoga, Boureima (Mali)1; Diallo, Fatimata (Mali)1; Fane, Bintou (Mali)1; Coulibaly, Gagni (Mali)1; Baya, Bocar (Mali)1; Somboro, Amadou (Mali)1; Sarro, Yeya Dit Sadio (Mali)1; Orsega, Suzanne (United States of America)4; Deun, Armand Van (Belgium)3; Dissou, Affolabi (Benin)5; Rigouts, Leen (Belgium)3; Murphy, Robert L (United States of America)6; Doumbia, Seydou (Mali)1; Diallo, Souleymane (Mali)1; De Jong, Bouke C (Belgium)3
1 - University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; 2 - Laboratoire National de Référence des Mycobactéries (LNR), Institut National de Recherche en Santé publique (INRSP); 3 - Institute of Tropical Medicine Antwerp, Belgium; 4 - Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA; 5 - Laboratoire National de Référence des Mycobactéries (LNR), Cotonou, Benin; 6 - Global Health, Northwestern University, Chicago, IL, USA; 7 - University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali,
Mhimbira, Francis
PO - (8565) - PREVALENCE AND CLINICAL SIGNIFICANCE OF RESPIRATORY VIRUSES AND BACTERIA DETECTED IN TUBERCULOSIS PATIENTS COMPARED TO HOUSEHOLD CONTACT CONTROLS IN TANZANIA
Mhimbira, Francis (Tanzania)1; Hella, Jerry (Tanzania)1,2,3; Hiza, Hellen (Tanzania)1; Mbuba, Emmanuel (Tanzania)1; Chiryamkubi, Magreth (Tanzania)4; Gagneux, Sebastien (Switzerland)2,3; Fenner, Lukas (Tanzania)5
1 - Ifakara Health Institute; 2 - Swiss Tropical and Public Health Institute; 3 - University of Basel; 4 - Ministry of Health, Community Development, Gender, Elderly and Children; 5 - Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Monitor 3: Malaria
E-poster Presentation
Sala / Room 2
Hilda, Echelibe
PO - (8271) - PFHRP2 GENE DELETIONS IN PLASMODIUM FALCIPARUM AND SCHISTOSOMA MANSONI CO-INFECTIONS: AN EMERGING CHALLENGE FOR MALARIA RAPID DIAGNOSTIC TESTS
Hilda, Echelibe (Cameroon)1,2,3
1 - Netongo Palmer Masumbe; 2 - Akindeh Nji; 3 - Mbacham Wilfred
Botchway, Felix
PO - (8353) - THE ROLE OF HEME AND CXCL10 IN MALARIA PATHOGENESIS IN GHANAIANS
Botchway, Felix (Ghana)1; Lekpor, Cecilia (Ghana)1; Wilson, Nana Otu (United States of America)2; Stiles, Jonathan (United States of America)2
1 - University of Ghana/Korle-Bu Teaching Hospital; 2 - Morehouse School of Medicine
Otu, Paulina
PO - (8355) - HOST GENETIC POLYMORPHISMS AND ASYMPTOMATIC MALARIA IN SOUTHERN GHANA
Otu, Paulina (Ghana)1
1 - University of Ghana
Lekpor, Cecilia
PO - (8356) - ANGIOGENIC AND ANGIOSTATIC FACTORS IN THE SALIVA OF MALARIA PATIENTS
Lekpor, Cecilia (Ghana)1; Botchway, Felix (Ghana)1; Stiles, Jonathan (United States of America)2; Nana, Wilson Otoo (United States of America)2
1 - Department of Patholgy/ University of Ghana; 2 - Morehouse School of Medicine
Akpéyédjé, Dossou
PO - (8458) - POLYMORPHISM OF THE PLASMODIUM FALCIPARUM MSP-2 GENE ASSOCIATED WITH PLACENTAL MALARIA AT THE BORGOU-ALIBORI DEPARTMENTAL HOSPITAL
Akpéyédjé, Dossou (Benin)1; Issifou, Saadou (Benin)1
1 - FORS (Fondation pour le Recherche Scientifique)
Badu, Kingsley
PO - (8562) - SECRETED OKINETE PROTEIN AS A MARKER OF INFECTIOUS BITES FOR ASSESSING TRANSMISSION DYNAMICS AT THE POPULATION LEVEL
Badu, Kingsley (Ghana)1
1 - Kwame Nkrumah University of Science and Technology
Ansumana, Rashid
PO - (8584) - MULTIPLEXED MOLECULAR DETECTION OF MALARIA IN SIERRA LEONE
Ansumana, Rashid (Sierra Leone)1
1 - Mercy Hospital Research Laboratory
Funwei, Roland
PO - (8607) - DETECTION OF PLASMODIUM FALCIPARUM HISTIDINE-RICH PROTEIN 2/3(PFHRP-2/PFHRP-3)GENES DELETION AND AMINO ACID NUCLEOTIDE SEQUENCE VARIABILITY IN NIGERIA
Funwei, Roland (Nigeria)1,2; Falade, Catherine (Nigeria)1; Ojurongbe, Olusola (Nigeria)3
1 - Department of Pharmacology and Therapeutics, University of Ibadan; 2 - Department of Pharmacy Technician Studies, Bayelsa State College of Health Technology; 3 - Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Osogbo
13:30
13:45
The TB Vaccine Development Pathway: a new tool guide vaccine developers and funders
Launch Event
Sala / Room 4
Organiser: TuBerculosis Vaccine Initiative (TBVI, Netherlands)
The TB Vaccine Development Pathway is a newly established tool that provides a structured development path and gating criteria for candidate TB vaccines. It describes the different functions and capabilities that are required to advance a candidate TB vaccine to its next stage of development.
14:00
16:00
Empowering African research institutions through capacity building, partnership and networking
Scientific Symposium
Auditorium 2
Organiser(s): Institut de Recherche, de Surveillance Epidémiologique et de Formation (IRESSEF, Senegal)
In 2017, the EDCTP provided funding to four African regional networks of excellence: TESA, WANETAM, CANTAM and EACCR. These networks aim to:
1. Provision of training, career and professional development and scientific leadership opportunities within the networks. Through this objective formal training, career development and mentorship are provided to scientists. Work-based competency training is provided in essential skills needed to support science at the laboratory, field, data and clinical levels.
2. Building of platforms to support research, covering the provision of necessary equipment, user training, joint resources for data management, bio-repositories, collaborative surveillance systems and networks, and research management.
3. Networking amongst scientists for collaborative research, advocacy and wider scientific leadership in Africa, including improved collaboration amongst scientists, (South-south and North-South) for joint collaborative grant applications and implementation.
4. Build capacity for conducting innovative research that will support clinical trials and implementation research activities.
A summary of key successes are highlighted below:
• A solid base of PhDs, MScs and other competency-based trainings have been provided by sister institutions within the consortia. Ten online training programmes have also been developed.
• In the WANETAM network, two laboratories have successfully achieved ISO15189 accreditation. Five other laboratories are currently undergoing internal assessment and will commence the accreditation process soon.
• The CANTAM network is engaged in a central African clinical trial phase IIIB/IV on an antimalarial drug (pyramax pharmacovigilance study).
• The EACCR has successfully obtained accreditation for 5 laboratories and 17 sites, obtaining significant infrastructural development, including setting up data management centres, enlarging biorepositories, and procurement of essential equipment.
The increase in the accreditation of laboratories is a clear manifestation of impact of the networks. Shared resources generated for biobanking, data centres, and grant management support are now shared amongst several institutions.
Improving West African research institutions through capacity building and networking: the approach of WANETAM
Scientific Symposium
Auditorium 2
Accelerating/increasing opportunities for capacity building for internationally recognized clinical research through training, support and networking - the EACCR story
Scientific Symposium
Auditorium 2
The story of CANTAM, empowering central African institutions through capacity development and partnership networking
Scientific Symposium
Auditorium 2
Strengthening and expanding clinical research capacities – TESA experience
Scientific Symposium
Auditorium 2
Rodrigues Fernando Matcheve
Overview: successes and challenges of running Nodes of Excellence
Scientific Symposium
Auditorium 2
Focus areas for a synergy between industry and the 4 EDCTP NoEs
Scientific Symposium
Auditorium 2
Future collaboration between Industry and EDCTP NoEs
Scientific Symposium
Auditorium 2
14:00
16:00
Partnerships jointly making a difference for preschool-age children with schistosomiasis
Scientific Symposium
Auditorium 3
Organiser(s): Lygature (The Netherlands)
Although fully acknowledged by WHO as a major health issue, the estimated 25 million Preschool-Age Children (PSAC) suffering from schistosomiasis are currently left without proper treatment. To reduce the global disease burden of schistosomiasis from the individual patient to the endemic country level, various partnerships are addressing the medical need of infected PSAC:
The Pediatric Praziquantel Consortium is developing a pediatric praziquantel tablet formulation suitable for PSAC, which is currently lacking. Prof. Eliézer N’Goran will present his experience of implementing the phase II trial in resource-limited settings and the added-value of working within a public-private partnership.
TIBA, an African-led partnership, is investigating better ways to access Schistosoma-infected PSAC in the context of the different child health primary care systems in place in partner countries. Apart from initial findings, Prof. Francisca Mutapi will stress the importance that African countries jointly explore and draw lessons from the ways that different African health systems tackle infectious diseases.
On behalf of COUNTDOWN, Prof. Louis-Albert Tchuem Tchuente will explain that treatment alone is not sufficient to achieve the interruption of schistosomiasis transmission, but will require multi-sectorial interventions, including health education; access to clean water, sanitation improvement, and environmental snail control.
Finally, Dr Govert Van Dam from FREEBILY will explain the importance of accurate diagnostics in schistosomiasis and will show the usefulness of point-of-care as well as laboratory diagnostic tests for controlling intestinal schistosomiasis in young children. He will also share results from collaborative diagnostic projects in Africa and other endemic areas.
Although completely autonomous, the four partnerships are interconnected at different levels to ensure a proper exchange of knowledge, results and possibly materials. More importantly, with public and private organizations from 8 non-African and 14 African countries, the partnerships combined demonstrate that the health burden of Schistosoma-infected PSAC is being addressed by a genuine and broad North-South partnership.
Setting the stage: pivotal role for partnerships in pediatric schistosomiasis
Scientific Symposium
Auditorium 3
Successful implementation of a phase II trial of two new pediatric praziquantel tablet formulations in resource-limited settings (PZQ4PSAC)
Scientific Symposium
Auditorium 3
Innovative approaches to pediatric schistosome control: leveraging our understanding of health systems in sub-Saharan Africa (TIBA)
Scientific Symposium
Auditorium 3
Thinking beyond treatment: priority interventions to achieve the interruption of schistosomiasis transmission (COUNTDOWN)
Scientific Symposium
Auditorium 3
Louis-Albert Tchuem Tchuenté
CAA and CCA detection in schistosomiasis: ASSURED diagnostic tools to be employed when moving from control to elimination (Freebily)
Scientific Symposium
Auditorium 3
What’s next: moving beyond PSAC, and addressing the needs of girls and women with schistosomiasis
Scientific Symposium
Auditorium 3
14:00
16:00
TB vaccine development: the results of unique collaborative effort
Scientific Symposium
Sala / Room 4
Organiser(s): TuBerculosis Vaccine Initiative (TBVI, The Netherlands)
The UN Sustainable Development Goals call for ending tuberculosis (TB) by 2035. This ambitious goal is unlikely to be met without safe, efficacious and affordable novel TB vaccines. WHO has identified an urgent need for new vaccines that prevent all forms of TB, including disease caused by drug-resistant strains, in all age groups, and including people living with HIV. In order to meet those needs, the development of novel TB vaccines needs to be accelerated through increased collaboration and sustained funding.
The symposium will provide an overview of recent progress in the development of TB vaccines, results from collaborative efforts, identify opportunities for collaboration and highlight the crucial role that EDCTP is playing in the clinical development of TB vaccine candidates.
The introductory presentation will cover the current state of the TB vaccine pipeline and describe a stage gating approach developed by Aeras and TBVI. The stage gating approach is intended as a tool for the TB vaccine community to support the development of novel vaccine candidates and facilitate portfolio investment decisions.
This presentation will be followed by a series of presentations on four large TB vaccine clinical trials recently funded by EDCTP. Twenty-eight research institutions from sub-Saharan Africa, Europe and India will work closely together on these trials. These trials will evaluate three different vaccine candidates, H56:IC31, VPM1002 and MTBVAC, and represent the largest European investment into clinical development of TB vaccines to date.
Introduction
Scientific Symposium
Sala / Room 4
Portfolio TB vaccines in research & development, stage-gate, populations and platforms
Scientific Symposium
Sala / Room 4
MTBVAC, a new live attenuated TB Vaccine
Scientific Symposium
Sala / Room 4
PriMe
Scientific Symposium
Sala / Room 4
A collaborative approach to good participatory practice implementation across EDCTP-funded TB vaccine clinical trials
Scientific Symposium
Sala / Room 4
The POR-TB consortium, assessing the efficacy of a vaccine for prevention of recurrent TB.
Scientific Symposium
Sala / Room 4
Q&A and conclusions
Scientific Symposium
Sala / Room 4
16:00
16:30
Coffee Break
Break
Foyer 1
16:30
18:00
Vaccines for neglected diseases
Parallel Session
Auditorium 2
Vermaak, Samantha
OC - (8259) - THE VALIDATE NETWORK: EXPLOITING SYNERGIES BETWEEN COMPLEX INTRACELLULAR NEGLECTED PATHOGENS TO EXPEDITE VACCINE R&D FOR TUBERCULOSIS, LEISHMANIASIS, LEPROSY AND MELIOIDOSIS
Vermaak, Samantha (United Kingdom)1; Fletcher, Helen (United Kingdom)2; Mcshane, Helen (United Kingdom)1
1 - The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; 2 - The London School of Hygiene and Tropical Medicine, London, UK
Leroy, Odile
OC - (8489) - CLINICAL DEVELOPMENT OF A THERAPEUTIC VACCINE FOR PREVENTION OF POST KALA AZAR DERMAL LEISHMANIASIS
Kaye, Paul (United Kingdom)1; Musa, Ahmed (Sudan)2; Olobo, Joseph (Uganda)6; Mbuchi, Margaret (Kenya)5; Mekuria, Asrat Hailu (Ethiopia)3; D'alessio, Flavia (Germany)4; Houard, Sophie (Germany)4; Leroy, Odile (Germany)4
1 - University of York; 2 - University of Khartoum, Institute of Endemic Diseases; 3 - University of Gondar; 4 - European Vaccine Initiative; 5 - Kenya Medical Research Institute; 6 - Makerere University
Zinsou, Jeannot Frejus
OC - (8521) - PRELIMINARY REPORT ON SAFETY OF CO-ADMINISTERED HUMAN HOOKWORM VACCINE CANDIDATES NA-APR-1 (M74)/ALHYDROGEL® AND NA-GST-1/ALHYDROGEL® IN GABONESE CHILDREN.
Zinsou, Jeannot Frejus (Gabon)1; Honpkehedji, Josiane (Gabon)1; Jean Claude, Dejon Agobe (Gabon)1; Adegbite, Romeo (Gabon)1; Edoa, Jean Ronald (Gabon)1; Van Leeuwen, Remko (Netherlands)2; Diemert, David (United States of America)3; Botazzi, Maria Elena (United States of America)4; Kremsner, Peter (Germany)5; Yazdanbakhsh, Maria (Netherlands)6; Hotez, Peter (United States of America)4; Grobusch, Martin P. (Netherlands)2; Adegnika, Ayola Akim (Gabon)1; De Vries, Sophie (Netherlands)2
1 - Centre de Recherches Médicales de Lambaréné; 2 - Academic Medical center; 3 - George Washington University School of Medicine & Health Sciences; 4 - Baylor College of Medicine and Texas Children’s Hospital; 5 - Institut für Tropenmedizin, Universität Tübingen, Tübingen,Germany; 6 - Leiden University Medical Center
Wilson, Seanette
OC - (8465) - THE DEVELOPMENT OF A CONJUGATE VACCINE AGAINST GROUP B STREPTOCOCCUS: AN AFRICAN PERSPECTIVE
Wilson, Seanette (South Africa)1; Tippoo, Patrick (South Africa)1
1 - The Biovac Institute
Imbault, Nathalie
OC - (8745) - NEW VACCINES FOR A SAFER WORLD
Imbault, Nathalie (Norway)1; Grant, Rachel (Norway)1
1 - CEPI
16:30
18:00
Strengthening systems through partnerships
Parallel Session
Auditorium 3
Wurie, Haja
OC - (8586) - INSTITUTIONAL RESEARCH CAPACITY BUILDING FOR MULTI-DISCIPLINARY HEALTH RESEARCH TO SUPPORT THE HEALTH SYSTEM REBUILDING PHASE IN SIERRA LEONE
Wurie, Haja (Sierra Leone)1
1 - College of Medicine and Allied Health Sciences, University of Sierra Leone
Dominicus, Hanneke
OC - (8469) - REVIEWING INVESTIGATIONAL PRODUCT’S QUALITY ASSURANCE DOCUMENTATION IN MAJOR CLINICAL TRIAL REGISTRIES FOR POST-MARKETING CLINICAL TRIAL STUDIES
Doua, Joachim (Belgium)1,2; Dominicus, Hanneke (Netherlands)1,3
1 - Consortium for African Regulatory Expertise Development (CARED), Voorburg, The Netherlands; 2 - Benelux Pharmacovigilance Office, Global Medical Organization, Johnson&Johnson; 3 - Dominicus Medicus Consultancy, Voorburg, The Netherlands
Saint-Raymond, Agnes
OC - (8431) - CLINICAL RESEARCH AND SUSTAINABLE DEVELOPMENT IN SUB-SAHARAN AFRICA: THE IMPACT OF NORTH-SOUTH PARTNERSHIPS
Saint-Raymond, Agnes (United Kingdom)1; Harvey, Martin (United Kingdom)1; Cavaller, Maria (United Kingdom)1
1 - European Medicines Agency
16:30
18:00
HIV
Parallel Session
Sala / Room 4
Joseph, Sarah
OC - (8491) - PREPVACC: A PHASE III, MAMS ADAPTIVE PROPHYLACTIC HIV VACCINE TRIAL WITH A SECOND RANDOMISATION TO COMPARE F/TAF WITH TDF/FTC PREP
Joseph, Sarah (United Kingdom)1; Kaleebu, Pontiano (Uganda)2; Ruzagira, Eugene (Uganda)2; Holm Hansen, Christian (Uganda)2; Seeley, Janet (Uganda)2; Basajja, Vincent (Uganda)2; Weber, Jonathan (United Kingdom)3; Fox, Julie (United Kingdom)3; Kingsley, Cherry (United Kingdom)3; Aboud, Said (Tanzania)4; Lyamuya, Eligius (Tanzania)4; Maganga, Lucas (Tanzania)5; Pamba, Doreen (Tanzania)5; Ramjee, Gita (South Africa)6; Yssel, Justin (South Africa)6; Viegas, Edna (Mozambique)7; Jani, Ilesh (Mozambique)7; Priddy, Fran (United States of America)8; Nilsson, Charlotta (Sweden)9; Kroidl, Arne (Germany)10; Pantaleo, Giuseppe (Switzerland)11; Robb, Merlin (United States of America)13; Crook, Angela (United Kingdom)12; Dunne, David (United Kingdom)12; Mccormack, Sheena (United Kingdom)12
1 - Human Immunology Laboratory,Imperial College of Science, Technology and Medicine; 2 - MRC/UVRI and LSHTM Uganda Research Unit; 3 - Imperial College of Science and Technology; 4 - Muhimbili University of Health & Allied Sciences; 5 - NIMR-Mbeya Medical Research Center; 6 - South African Medical Research Council; 7 - Instituto Nacional de Saúde; 8 - International AIDS vaccine Initiative; 9 - Public Health Agency of Sweden; 10 - Ludwig-Maximilians-Universitat; 11 - Centre Hospitalier Universitaire Vaudois; 12 - MRC Clinical Trials Unit at University College; 13 - US Military Research Programme
Hanke, Tomas
OC - (8499) - THE T-CELL VACCINE STRATEGY: GLOBALLY RELEVANT AIDS VACCINE EUROPE-AFRICA TRIALS PARTNERSHIP (GREAT)
Hanke, Tomas (United Kingdom)1; Fast, Pat (United States of America)2; Kaleebu, Pontiano (Uganda)3; Jaoko, Walter (Kenya)4; Sanders, Eduard (Kenya)5; Kilembe, William (Zambia)6; Kuipers, Hester (United States of America)2; Okech, Brenda (Uganda)7; Gilmour, Jill (United Kingdom)8
1 - University of Oxford; 2 - IAVI; 3 - UVRI; 4 - IAVI-ICR; 5 - KEMRI-Kilifi; 6 - ZEHRP; 7 - UVRI-IAVI; 8 - HIL-IAVI
Kityo, Cissy
OC - (8450) - ABSENCE OF MINORITY HIV-1 DRUG RESISTANT VARIANTS FOLLOWING MOTHER-TO-CHILD TRANSMISSION DOES NOT PREDICT VIROLOGIC SUCCESS TO FIRST-LINE ANTIRETROVIRAL THERAPY
Kityo, Cissy (Uganda)1; Rinke De Wit, Tobias (Netherlands)2,3; Nankya, Immaculate (Uganda)4; Balinda, Sheilla (Uganda)5; Sigaloff, Kim (Netherlands)2,6; Ndashimye, Emmanuel (Netherlands)4; Mugyenyi, Peter (Uganda)7; Quinones-Mateu, Miguel (United States of America)8,9
1 - Joint Clinical Research Centre; 2 - Amsterdam Institute for Global Health and Development (AIGHD); 3 - Academic Medical Center of the University of Amsterdam (AMC-UvA); 4 - Center for AIDS Research (CFAR) Uganda Laboratories, Joint Clinical Reserch Centre; 5 - MRC/UVRI & LSHTM Uganda Research Unit; 6 - Leiden University Medical Center (LUMC); 7 - Joint Clinical Reserch Centre; 8 - Case Western Reserve University, Cleveland, Ohio; 9 - University Hospitals Cleveland Medical Center, Cleveland, Ohio
Loyse, Angela
OC - (8494) - DRIVING REDUCED AIDS-ASSOCIATED MENINGO-ENCEPHALITIS MORTALITY
Loyse, Angela (United Kingdom)1; Mfinanga, Dr Sayoki (Tanzania)2; Kanyama, Dr Cecilia (Malawi)3; Kounfack, Dr Charles (Cameroon)6; Lesikari, Sokoine (Tanzania)4; Chawinga, Chimwemwe (Malawi)5; Stack, Muirgen (United Kingdom)8; Molloy, Dr Sile (United Kingdom)7
1 - DREAMM Project Chief Investigator, Senior Clinical Lecturer, St Georges, University of London; 2 - DREAMM PI, NIMR, Muhimbili Medical Research Centre, Tanzania; 3 - DREAMM PI, UNC Project-Malawi, Kamuzu Central Hospital, Malawi; 4 - NIMR, Muhimbili Medical Research Centre, Tanzania,; 5 - UNC Project-Malawi, Kamuzu Central Hospital, Malawi,; 6 - PI, Hȏpital Central Yaoundé/Site ANRS, Cameroon; 7 - Co-Investigator/Epidemiologist, St Georges University of London; 8 - Project Co-ordinator, St Georges University of London
Thursday, 20 September 2018
08:00
17:00
Registration
Registration Desk
09:00
10:15
Plenary Session V
Plenary Session
Auditorium 1
Tribute to Professor Ogobara Doumbo: achievements and contributions to African malaria research
Keynote Address
Auditorium 1
Targeting the malaria parasite: from lab innovation to new interventions
Keynote Address
Auditorium 1
Maria Mota - Instituto de Medicina Molecular João Lobo Antunes
10:15
11:00
Coffee break
Break
Foyer 1
11:00
13:00
The Aga Khan Development Network and Foundation for Science and Technology Research Collaboration in Health, Clinical and Translational Research in Africa
Scientific Symposium
Auditorium 2
Organiser: Fundação para a Ciência e a Tecnologia (Portugal)
This symposium aims at showcasing four projects in the area of health, clinical and translational research to be funded under the first Aga Khan Development Network (AKDN) and Foundation for Science and Technology’s (FCT) joint call for proposals, implemented in 2017 and 2018.
The joint call emanated from the Protocol of Cooperation in Science and Technology co-signed by the Ismaili Imamat and Portugal’s Ministry for Science, Technology and Higher Education, whose underlying tenets recognise the long effort of the Ismaili Imamat to foster the welfare of people in Africa; and the large experience of the AKDN in building scientific and technical capacity in Portugal, officially Portuguese-speaking African countries, and elsewhere in Africa. This call generated sixteen projects altogether serving a concept of quality of life encompassing food security and biodiversity, early childhood development, education policies and assessment, habitat, sustainable energy systems and urban development, poverty alleviation, and resettlement of migrants, civil society and pluralism, and beyond.
Aligned with the EDCTP2 programme, these four projects hold different foci and will be performed in three African countries. While capacitating Angola with an anti-malarial reference centre, project MalAngo aims at profiling antimalarial resistance to Plasmodium falciparum and subsequent need, or not, to review the guidelines for treatment in Angola. In turn, project Maf_TB seeks to describe the genetic diversity of circulating Mycobacterium tuberculosis complex in Guinea-Bissau, and how this relates to drug resistance profiles in the country. Project SCAFfoldChild takes Next Generation Sequencing to identify genetic predictors of fetal hemoglobin response to hydroxyurea in Angolan children with sickle-cell disease belonging to the Bengo General Hospital cohort. At last, contributing to better prevent and control HIV infection in the country, project CVHIVCo aims at obtaining a detailed understanding of the HIV epidemiology, drug resistance and pathogenesis in Cape Verde.
Opening Address
Scientific Symposium
Auditorium 2
MalAngo: malaria drug resistance: treatment alternatives and optimization – a project strengthening a national reference centre for anti-malarial clinical trials and capacity building in Angola
Scientific Symposium
Auditorium 2
Maf_TB: understanding host-pathogen interactions in tuberculosis – lessons from Mycobacterium africanum
Scientific Symposium
Auditorium 2
SCAFfoldChild: sickle cell anemia and fetal haemoglobin – genetic modifiers in an Angolan children cohort
Scientific Symposium
Auditorium 2
CVHIVCo: epidemiology, drug resistance and pathogenesis of HIV in Cape Verde – the Cape Verde HIV cohort”
Scientific Symposium
Auditorium 2
11:00
13:00
From product development to impact: Exploring the role of operational research within the malaria R&D funding landscape
Scientific Symposium
Auditorium 3
Organiser: PATH (United States of America)
Alexandra Fullem - Global Health Consultant
Welcome and Introduction
Scientific Symposium
Auditorium 3
Presentation of malaria R&D funding study
Scientific Symposium
Auditorium 3
Case study 1: Using operational research for malaria elimination in four South African countries
Scientific Symposium
Auditorium 3
Case Study 2: Using operational research to implement a rapid diagnostic test for different uses, including malaria in pregnancy
Scientific Symposium
Auditorium 3
Case Study 3: Severe Malaria Observatory – MMV’s living platform to gather and disseminate shared country experiences in transforming severe malaria case management with new improved tools becoming more widely used
Scientific Symposium
Auditorium 3
EDCTP’s perspective on malaria R&D funding and in particular, the importance of implementation and operational research
Scientific Symposium
Auditorium 3
11:00
13:00
Tuberculosis
Parallel Session
Sala / Room 4
Olbrich, Laura
OC - (8561) - RAPAED TB – AN INNOVATIVE CHILD TB DIAGNOSTIC VALIDATION STUDY
Olbrich, Laura (Germany)1; Zar, Heather (South Africa)2; Graham, Steve (Australia)3; Sabi, Issa (Tanzania)4; Ntinginya, Nyanda (Tanzania)4; Bhatt, Nilesh (Mozambique)5; Nliwasa, Marriott (Malawi)6; Corbett, Elizabeth (United Kingdom)7; Song, Rinn (United Kingdom)8; Denkinger, Claudia (Switzerland)9; Hölscher, Michael (Germany)1; Heinrich, Norbert (Germany)1
1 - Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU); 2 - Red Cross War Memorial Children’s Hospital, MRC Unit on Child and Adolescent Health Unit, Cape Town, South Africa; 3 - University of Melbourne; 4 - NIMR - Mbeya Medical Research Programme; 5 - Instituto Nacional de Saúde (INS) - Mozambique; 6 - Malawi College of Medicine, Blantyre; 7 - London School of Hygiene and Tropical Medicine; 8 - Oxford Vaccone Group, University of Oxford; 9 - FIND (Foundation for Innovative New Diagnostics)
13:00
14:00
Lunch
Break
Foyer 1
13:15
14:00
E-Poster Presentations
E-poster Presentation
Sala / Room 1
Monitor 1: Malaria
E-poster Presentation
Sala / Room 1
Mbouamboua, Yvon
PO - (8249) - SUBMICROSCOPIC PLASMODIUM FALCIPARUM INFECTIONS IN MATCHED PERIPHERAL, PLACENTAL AND UMBILICAL CORD BLOOD SAMPLES FROM CONGOLESE WOMEN AT DELIVERY.
Mbouamboua, Yvon (Congo)1; Koukouikila-Koussounda, Félix (Congo)2; Helden, Jacques Van (France)3; Ntoumi, Francine (Congo)1
1 - Fondation Congolaise pour la Recherche Médicale; 2 - Fondation Congolaise pour le Recherche médicale; 3 - 5Aix-Marseille Univ, INSERM UMR_S 1090, Theory and Approaches of Genome Complexity (TAGC), F-13288 Marseille, France
Maiga, Hamma
PO - (8269) - SELECTION OF SEVEN-MUTATION PFCRT-PFMDR1 GENOTYPE AFTER SCALING-UP SEASONAL MALARIA CHEMOPREVENTION WITH SULPHADOXINE-PYRIMETHAMINE AND AMODIAQUINE IN MALI
Maiga, Hamma (Mali)1; Bamadio, Amadou (Mali)2; Traore, Aliou (Mali)2; Diallo, Nouhoum (Mali)2; Diarra, Modibo (Mali)2; Sagara, Issaka (Mali)2; Niangaly, Hamidou (Mali)2; Coumare, Samba (Mali)2; Sangare, Boubou (Mali)2; Traore, Djibril (Mali)2; Vaillant, Michel (Luxembourg)3; Dicko, Alassane (Mali)2; Doumbo, Ogobara (Mali)2; Djimde, Abdoulaye (Mali)2
1 - INRSP-Mali; 2 - MRTC; 3 - LIH
Whegang-Youdom, Solange
PO - (8370) - A REVIEW OF ANTI-MALARIAL THERAPEUTIC EFFICACY TRIALS IN CAMEROON
Whegang-Youdom, Solange (Cameroon)1; Chiabi, Andreas (Cameroon)2; Basco K, Leonardo (France)3
1 - National Advanced School of Engineering-University of Yaounde I; 2 - Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon; 3 - Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France
Niang, Makhtar
PO - (8419) - SPATIO-TEMPORAL MAPPING OF ASYMPTOMATIC AND CLINICAL MALARIA INFECTIONS REVEALS FOCI OF MALARIA TRANSMISSION FOR TARGETED CONTROL INTERVENTIONS
Niang, Makhtar (Senegal)1; Talla, Cheikh (Senegal)2; Diagne, Nafissatou (Senegal)3; Diene-Sarr, Fatoutama (Senegal)4; Sokhna, Cheikh (Senegal)3
1 - Immunology Unit, Institut Pasteur de Dakar; 2 - Epidemiology Unit, Institut Pasteur of Dakar, Senegal; 3 - Institute for Research and Development, Dakar, Senegal; 4 - Epidemiology Unit, Institut Pasteur de Dakar, Senegal
Anjorin, Oluwafunmibi
PO - (8448) - ADVERSE DRUG REACTION TO TWO ARTEMISININ BASED COMBINATION THERAPIES-ARTEMETHER-LUMEFANTRINE AND ARTEMISININ-PIPERAQUINE IN CHILDREN WITH ACUTE UNCOMPLICATED MALARIA IN IBADAN, NIGERIA
Anjorin, Oluwafunmibi (Nigeria)1; Falade, Catherine Olufunke (Nigeria)1
1 - Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria
Diarra, Amidou
PO - (8492) - REPEATED ARTEMISININ BASE TREATMENT ON MALARIA SEXUAL PARASITE DISTRIBUTION IN POPULATION LIVING IN A MALARIA ENDEMIC AREA OF BURKINA FASO
Diarra, Amidou (Burkina Faso)1; Soulama, Issiaka (Burkina Faso)1; Nebie, Issa (Burkina Faso)1; Ouattara, Maurice (Burkina Faso)1; Kabore, Moise (Burkina Faso)1; Sombie, Benjamin (Burkina Faso)1; Tiono, Alfred (Burkina Faso)1; Ouedraogo, Alphonse (Burkina Faso)1
1 - CNRFP
Badu, Kingsley
PO - (8496) - ACCURACY OF DIAGNOSIS AND HEMATOLOGICAL DIFFERENCE AMONG MALARIA PATIENTS IN RURAL AND URBAN AREAS IN THE ASHANTI REGION OF GHANA
Mutala, Abdul-Hakim (Ghana)1; Badu, Kingsley (Ghana)1; Tweneboah, Austine (Ghana)1; Agordzo, Samuel (Ghana)1; Abbas, Dawood Ackom (Ghana)1
1 - Department of Theoretical and Applied Biology, KNUST
Olaleye, Atinuke
PO - (8502) - DETERMINANTS AND PREVALENCE OF PARASITE RESISTANCE AMONG PREGNANT WOMEN RECEIVING IPTP WITH SULPHADOXINE-PYRIMETHAMINE IN NIGERIA
Olaleye, Atinuke (Nigeria)1; Uyaiabasi, Noblefather (Nigeria)2; Elikwu, Charles (Nigeria)3; Walker, Oladapo (Nigeria)2
1 - Dept of Obstetrics & Gynecology, Babcock University, Ilishan-Remo, Ogun state; 2 - Dept of Pharmacology, Babcock University, Ilishan-Remo, Ogun state; 3 - Dept of Medical Microbiology, Babcock University, Ilishan-Remo, Ogun state
Akano, Kazeem
PO - (8542) - CLINICAL ILLNESS AND OUTCOMES IN NIGERIAN CHILDREN WITH PERSISTENT EARLY APPEARING ANAEMIA FOLLOWING ARTEMISININ-BASED COMBINATION TREATMENTS OF UNCOMPLICATED FALCIPARUM MALARIA
Akano, Kazeem (Nigeria)1; Fatunmbi, Bayo (Uganda)3; Ntadom, Godwin (Nigeria)2; Alebiosu, Omobolaji T. (Nigeria)1; Akpoborie, Odafe (Nigeria)1; Okafor, Chukwuebuka (Nigeria)1; Sowunmi, Akintunde (Nigeria)1
1 - Department of Pharmacology and Therapeutics, University of Ibadan; 2 - National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria; 3 - World Health Organization, Country Office, Kampala
Monitor 2: Capacity development
E-poster Presentation
Sala / Room 1
Nyanzi-Kabuye, Emily
PO - (8278) - BUILDING CAPACITY IN CONDUCTING CLINICAL RESEARCH IN A VIRTUAL SETTING: EXPERIENCES FROM THE EAST AFRICAN CONSORTIUM FOR CLINICAL RESEARCH (EACCR2)
Nyanzi-Kabuye, Emily (Uganda)1; Kaleebu, Pontiano (Uganda)1; Benard Kikaire, Benard (Uganda)1; Mmbaga, Blandina (Tanzania)2; Mfinanga, Sayoki (Tanzania)3; Peshu, Nobert (Kenya)4; Mukhtar, Maowia (Sudan)5
1 - Uganda Virus Research Institute; 2 - Kilimanjaro Clinical Research Institute; 3 - National Institute of Medical Research -Muhimbili; 4 - Kenya Medical Research Institute- Wellcome Trust; 5 - Institute of Endemic Diseases, University of Khartoum
Rapa, Elizabeth
PO - (8388) - THE PROFESSIONAL DEVELOPMENT SCHEME (PDS): CAPACITY DEVELOPMENT AND CAREER TRACKING FOR RESEARCHERS (WWW.GLOBALHEALTHTRAININGCENTRE.ORG/PDS)
Rapa, Elizabeth (United Kingdom)1
1 - University of Oxford
Oduor, Patience
PO - (8472) - EACCR-2 INSTITUTIONAL CLINICAL RESEARCH CAPACITY ASSESSMENT: CASE STUDY OF SIAYA COUNTY REFERRAL HOSPITAL, WESTERN KENYA
Oduor, Patience (Kenya)1; Wambura, Mary (Kenya)2; Mwai, Geoffrey (Kenya)2; Wandiga, Steve (Kenya)1
1 - Kenya Medical Research Institute (KEMRI); 2 - Siaya County Referral Hospital
Jamieson, Nina
PO - (8529) - INTRODUCING A UNIQUE RESEARCH CAPACITY DEVELOPMENT PLATFORM SUPPORTING PREPAREDNESS FOR EFFECTIVE COMBAT OF EPIDEMIC OUTBREAKS
Jamieson, Nina (United Kingdom)1; Lang, Trudie (United Kingdom)1
1 - University of Oxford
Angoissa Minsoko, Pamela Catherine
PO - (8538) - STRENGTHENING SOCIAL STRATEGIES TO ENGAGE SUB-SAHARAN AFRICAN SOCIETIES TO VALUE CLINICAL RESEARCH THE EXPERIENCE IN CONDUCTING CLINICAL TRIALS IN LAMBARÉNÉ
Angoissa Minsoko, Pamela Catherine (Gabon)1; Agnandji, Selidji Todagbe (Gabon)1,2
1 - Centre de Recherches Médicales de Lambaréné; 2 - , Institut für Tropenmedizin, Universitätsklinikum Tübingen, Germany
Lazarova, Angela
PO - (8564) - WHAT IS CLINICAL TRIAL QUALITY? A QUALITATIVE STUDY BASED ON INTERVIEWS WITH DIFFERENT STAKEHOLDERS CONDUCTING CLINICAL TRIALS IN SUB-SAHARAN AFRICA
Lazarova, Angela (Switzerland)1,2; Fuchs, Claudia (Switzerland)2; Burri, Christian (Switzerland)1,2
1 - Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland; 2 - University of Basel, Petersplatz 1, 4003 Basel, Switzerland
Mfinanga, Godfrey Sayoki
PO - (8573) - RESEARCH, MENTORSHIP AND SUSTAINABLE DEVELOPMENT: IS RETIREMENT AGE A HURDLE TO RESEARCH SUSTAINABILITY IN AFRICA: VIEWPOINTS
Ngadaya, Esther (Tanzania)1; Kitua, Andrew (Uganda)14; Castelnuovo, Barbara (Uganda)3; Mmbaga, Blandina (Tanzania)2; Mboera, Leonard (Tanzania)6; Kirenga, Bruce (Uganda)4; Yimer, Getnet (Ethiopia)5; Mukhtar, Maowia (Sudan)7; Wandiga, Steve (Kenya)8; Kwassi, Addo (Ghana)13; Kazwala, Rudovick (Tanzania)9; Bonfoh, Bassirou (Côte d'Ivoire)10; Kaleebu, Pontiano (Uganda)12; Mgaya, Yunus (Tanzania)1; Mfinanga, Godfrey Sayoki (Tanzania)11
1 - National Institute for Medical Research; 2 - Kilimanjaro Christian Research Institute; 3 - Infectious Diseases Institute — Mulago Hospital; 4 - Makerere University Lung Institute; 5 - Addis Ababa University; 6 - Southern African Centre for Infectious Disease Surveillance; 7 - Institute of Endemic diseases, University of Khartoum, Sudan; 8 - Kenya Medical research Centre; 9 - Sokoine University of Agriculture; 10 - Centre Suisse de Recherches Scientifiques; 11 - National Institute for Medical research, Muhimbili Research Centre; 12 - Uganda Virus Research Institute; 13 - Noguchi Memorial Institute for Medical Research; 14 - USAID/EPT-2 P&R project
Monitor 3: Vaccines and immunity
E-poster Presentation
Sala / Room 1
Hamdan, Hamdan
PO - (8208) - CYTOKINE PROFILES IN SUDANESE CHILDREN PRESENTED WITH SEVERE MALARIA, UNCOMPLICATED MALARIA COMPERED TO HEALTHY COMMUNITY CONTROLS ACCORDING TO WHO CRITERIA
Hamdan, Hamdan (Sudan)1; El-Misbah, Muna (Sudan)2; El-Awad, Tasneem (Sudan)1
1 - Al-Neelain University, Faculty of Medicine. Khartoum Sudan; 2 - Sudan International University. Khartoum , Sudan
Fogang, Balotin
PO - (8289) - ASSOCIATION BETWEEN PLASMA LEVELS OF IL-27, IL-6 CYTOKINES AND P. FALCIPARUM INFECTION IN PREGNANT WOMEN LIVING IN MBALMAYO, CAMEROON
Fogang, Balotin (Cameroon)1,2; Djontu, Jean Claued (Cameroon)1; Megnekou, Rosette (Cameroon)1; Ayong, Lawrence (Cameroon)2
1 - University of Yaounde I; 2 - Centre pasteur Cameroon
Betouke Ongwe, Madeleine Eunice
PO - (8439) - EFFECT OF PLASMODIUM FALCIPARUM EXPOSURE ON HUMAN URINARY METABOLOMICS PROFILING
Betouke Ongwe, Madeleine Eunice (Gabon)1; Verhoeven, Aswin (Netherlands)2; Adegnika, Akim Ayola (Gabon)1; Yazdanbakhsh, Maria (Netherlands)2; Mayboroda, Oleg (Netherlands)2
1 - Centre de recherche Medicale de Lambarene -Gabon; 2 - Leiden University Medical Center
Mbayo, Georgetta
PO - (8485) - INTERFERON GAMMA RESPONSE KINETICS IN TUBERCULOSIS PATIENTS AND HOUSEHOLD CONTACTS IN THE GAMBIA
Mbayo, Georgetta (Gambia)1; Garand, Mathieu (Gambia)1; Donkor, Simon (Gambia)1; Wathuo, Miriam (Gambia)1; Ottenhoff, Tom (Gambia)2; Owolabi, Olumuyiwa (Gambia)1; Sutherland, Jayne (Gambia)1
1 - Vaccines and Immunity Theme, Medical Research Council (MRC) Unit at London School of Hygiene and Tropical Medicine, Banjul, The Gambia; 2 - Department of Infectious Diseases, Leiden University Medical Center, The Netherlands
Ndong Mbouna, Armel Vivien
PO - (8559) - ASSESSMENT OF THE EFFECT OF RVSV REPLICATION ON NON-EBOLA CIRCULATING ANTIBODIES IN RVSV-ZEBOV-GP VACCINATED INDIVIDUALS IN LAMBARÉNÉ, GABON.
Ndong Mbouna, Armel Vivien (Gabon)1,3; Agnandji, Selidji Todagbe (Gabon)2,3
1 - Centre de Recherche de Lambarene, Gabon; 2 - Institut für Tropenmedizin, Universitätsklinikum Tübingen, Germany,; 3 - Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon
Ademowo, George
PO - (8571) - CYTOKINE PROFILE IN ASYMPTOMATIC SCHOOL CHILDREN CO-INFECTED WITH HELMINTH AND PLASMODIUM FALCIPARUM IN IBADAN, SOUTHWEST, NIGERIA
Ademowo, George (Nigeria)1; Rabiu, Olawunmi (Nigeria)2; Arinola, Ganiyu (Nigeria)2; Falade, Catherine (Nigeria)2
1 - University of Ibadan; 2 - College of Medicine, University of Ibadan, Ibadan, Nigeria
Nchinda, Godwin
PO - (8590) - COMPARATIVE ANALYSIS OF IGG RESPONSES TO RECOMBINANT QΒ PHAGE DISPLAYED MSP3 AND UBO5 IN DUAL HIV-MALARIA INFECTED ADULTS
Nchinda, Godwin (Cameroon)1; Lissom, Abel (Cameroon)2; Ouambo, Herve (Cameroon)3; Okeke, Malachy I (Norway)4; Tchouangueu, Thibau Flaurant (Cameroon)5; Tchouangueu, Loveline N. (Cameroon)6; Okoli, Arinze S (Norway)7; Achidi, Eric (Cameroon)3; Mbacham, Wilfred (Cameroon)8; Kaptue, Lazare (Cameroon)9; Esimone, Charles O. (Nigeria)10; Leke, Rose Fg (Cameroon)11; Waffo, Alain Bopda (United States of America)12
1 - Laboratory of vaccinology/biobanking CIRCB; 2 - Department of Animal Biology and Physiology, University of Yaoundé I; 3 - Department of Medical Laboratory Sciences, University of Buea, Cameroon; 4 - Molecular Inflammation Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037 Tromsø, Norway; 5 - Department of Biochemistry, University of Dschang, Cameroon; 6 - Department of Biochemistry University of Yaounde One; 7 - GenØk - Centre for Biosafety, Tromsø, Norway; 8 - The Department of Biochemistry and Physiology, Faculty of Medicine, University of Yaoundé I, Cameroon; 9 - Université des Montagnes, Bangangté, Cameroon; 10 - Department of Pharmaceutical Microbiology & Biotechnology, Nnamdi Azikiwe University Awka, Nigeria; 11 - The Biotechnology Center, University of Yaoundé I, Cameroon; 12 - Department of Biological Sciences/College STEM 1627 Hall Street Montgomery, AL 36101
Marcelino, José
PO - (8597) - NEUTRALIZING AND NON-NEUTRALIZING ANTIBODIES RESPONSE IN HIV-1 INFECTED INDIVIDUALS FROM MOZAMBIQUE.
Gonçalves, Paloma (Portugal)1; Martin, Francisco (Portugal)2; Borges, Patricia (Portugal)1; Espirito Santo, Maria (Mozambique)3; Taveira, Nuno (Portugal)2; Marcelino, José (Portugal)1
1 - Global Health and Tropical Medicine (GHTM), Unit of Medical Microbiology, Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL); 2 - Instituto de investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal; 3 - Instituto do Coração (Mozambique)
14:00
14:30
Plenary Session VI
Plenary Session
Auditorium 1
Guilherme d'Oliveira Martins - Calouste Gulbenkian Foundation
Eusébio Macete - Vice-Chair of the EDCTP Board and Director of Health Research Centre of Manhiça
14:30
17:30
EDCTP2 funding: from proposal submission to final reporting
Workshop
Auditorium 2
Organise(s)r: EDCTP and LINQ Management
In this interactive workshop, Dr Claudia Schacht and Julia Büch from LINQ management will walk the audience through the process of starting and composing an EDCTP application, giving practical advice on workplan setup, text writing and budget planning, and present the steps to be taken from positive evaluation of a proposal to the final signature of all relevant contractual documents. This will include a description of the different agreements, details on the grant preparation timeline and documents. Furthermore, essential processes and mechanisms of project implementation will be discussed, with practical tips on how to manage an EDCTP project successfully.
Presentations will be followed by a Q&A session, during which participants will have the opportunity to ask questions and share experiences. During the presentations and Q&A session, Jean Marie Vianney Habarugira (EDCTP Secretariat) will be responding to questions requiring specific input from the EDCTP Calls & Grants Department.
The objectives of this workshop are:
• to inform participants about the types of actions/projects supported by EDCTP2
• to inform participants about the required pre-application arrangements
• to guide the potential applicants through the online tool used to apply to EDCTP2
• to provide information on what is expected from applicants during the review process
• to inform successful applicants and potential future grant holders about what is expected from each beneficiary during the grant agreement preparation phase, the post-grant signing phase, the implementation and reporting phase.
Jean Marie Vianney Habarugira
14:30
17:30
Data sharing
Workshop
Auditorium 3
Organiser(s): The Global Health Network
With the “Open Science” revolution, researchers are expected to provide open access to information about their study’s methods, analyses and results; the pinnacle of this sharing revolution is the drive to sharing the actual study data, sometimes at an individual patient level. Funders argue that data sharing can enable faster evidence generation, better use of research funding, and improved research capacity - potentially bringing great benefit to researchers in low- and middle-income countries, or those working in disease outbreaks. However, data sharing is a relatively new phenomenon and considerable confusion still exists around what it means to share data, how it can be achieved, and how to overcome potential barriers.
In this workshop, we aim to cover the following learning objectives:
1. Be aware of the issues around data sharing,
2. Have the knowledge and tools to share their own data,
3. User feedback on tools.
We advise attendees to bring along a laptop, or tablet in order to participate in this interactive session. They will require access to a Wi-fi network.
Véronique Nintchom Penlap Spse Beng
14:30
17:30
Ethics considerations in EU-funded research: ethics evaluation and monitoring in EDCTP projects
Workshop
Sala / Room 4
Organisers: EDCTP and EU Ethics
Target audiences
-Researchers interested in applying to EDCTP2 calls
-Successful applicants with Grants under preparation
-Successful applicants with Grants under implementation
-Ethicists and members of ethics review committees
Background
In this interactive workshop, Romée Pameijer, independent ethics consultant, will walk the audience through ethical considerations in research, from planning your research proposal through to project implementation and end. The workshop will include an overview of the ethics evaluation procedure at EDCTP; the elements of the ethics self-assessment section of an EDCTP proposal; ethics requirements, ethics checks and audits during project implementation. Practical examples and challenges will be presented.
The presentation will be interactive with time for questions at defined points in the presentation, as well as a Q&A and discussion session at the end. During the presentation and Q&A session, Pauline Beattie (EDCTP Secretariat) will be responding to questions on EDCTP policies and procedures.
Learning Objectives
The objectives of this workshop are:
-to inform participants about ethical considerations in EDCTP-funded research
-to guide potential applicants through the ethics components of the EDCTP applicant form
-to provide information on what is expected from applicants during the review process
-to inform successful applicants and potential future grant holders about what is expected in terms of ethics requirements during the grant agreement preparation phase, the post-grant signing phase, the implementation and reporting phase.
Training Media&Materials
The workshop will be delivered through
-Presentations
-An interactive Q&A session
Friday, 21 September 2018
Site Visit 1 • IHMT - Institute of Hygiene and Tropical Medicine, University NOVA of Lisbon and iBET - Institute of Experimental Biology and Technology
by registration only
Bus departing from Calouste Gulbenkian Foundation
At IHMT:
•Insect Collection & Insectaries
•Visit to the TB Laboratories
•Visit to the Museum
•Chat with researchers
At iBET:
•Visit to the facilities with special emphasis on Malaria projects.
More Information:
Institute of Hygiene and Tropical Medicine, University NOVA of Lisbon
IHMT was founded in 1902. Main areas of activity are: vector borne diseases; HIV tuberculosis and opportunistic infections; Public Global Health, operating within the transversal subjects of: Global Pathogen dispersion and population mobility; Diagnosis and Drug/Insecticide discovery and resistance; and Public health information.
iBET, Institute of Experimental Biology and Technology
iBET is a private not for profit research intensive SME in the area of biotechnology and life sciences. iBET was established in 1989 and bridges university and industry research, by establishing partnerships particularly in the areas related to Health & Pharma and Food & Health.
Site Visit 4 • Gulbenkian Institute of Science (IGC)
by registration only
Bus departing from Calouste Gulbenkian Foundation
• Welcome to the IGC, Mónica Dias, Director
• IGC Science Development Programme., Patrícia Beldade
• Research at IGC
Targeting the alpha-gal glycan in malaria vaccines: Rationale and future perspectives, Miguel Soares
Malaria in pregnancy, Revealing a conflict of interests, Carlos Penha Gonçalves
Antiviral protection by intracellular bacteria: from basic science in Drosophila to prevention of mosquito-borne viruses transmission, Luís Teixeira and Discussion
•Visit to IGC: Research Laboratories, Imaging, Cytometry, Genomics and Histopathology Facilities
Site Visit 2 • Nova Medical School | Faculdade de Ciências Médicas
by registration only
Bus departing from Calouste Gulbenkian Foundation
Presentations of NMS investigators*
•Paulo Paixão, MD, PhD
•João Paço, MD, PhD
•Helena Soares, PhD
•Emília Monteiro, MD, PhD
Visit to CEDOC Laboratories & to the Old Building of NMS (3 of 6 participants in groups to rotate), and networking.
More Information:
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) is an academic unit of Universidade NOVA de Lisboa. Currently NMS|FCM has 1.671 students in the Integrated Master Degree in Medicine, 569 postgraduate students and a total of 546 professors and researchers. NMS|FCM is the Medical School with the best tutor/student ratio (1/3) during the clinical years in Portugal and its students obtain excellent results in the medical specialty assessment. NMS|FCM is associated with several health units, allowing a variety of learning environments and a more comprehensive knowledge of hospital reality and primary health care. In addition, the creation of the University Medical Center of Lisbon (Centro Médico Universitário de Lisboa - CMUL), a consortium between NMS|FCM and the Centro Hospitalar de Lisboa Central (CHCL), allow to offer better teaching and clinical research conditions. The NMS|FCM Research Campus provides the adequate environment for fundamental and clinical research.
The two research institutes of NMS|FCM are located in this venue: CEDOC - Centro de Estudos de Doenças Crónicas (Chronic Diseases Research Centre), integrated in a R&D Unit, iNOVA4Health, classified as Excellent, and ToxOmics - Centro de Toxicogenómica e Saúde Humana (Centre for Toxicogenomics and Human Health). NMS|FCM was awarded the Ministry of Health Gold Medal for Distinguished Services.
NOVA Medical School (NMS|FCM) Research Center CEDOC was created with the mission to pursuit excellence in basic, developmental, preclinical & clinical research, to better understand the molecular mechanisms of chronic diseases and to develop advanced and personalized therapies, which ultimately lead to an improvement of the quality of life and well-being of the population.
NMS|FCM brings together biomedical, translational and clinical research under a multidisciplinary and collaborative spirit, hosting a strong scientific critical mass with 34 research groups, 133 PhD researchers, 79 Clinicians, and 118 PhD student devoted to understanding a variety of chronic pathologies, from rare to metabolic and autoimmune diseases.
Site Visit 3 • Institute of Molecular Medicine João Lobo Antunes (iMM)
by registration only
Bus departing from Calouste Gulbenkian Foundation
• Presentation of iMM
• Luísa Figueiredo Lab - Parasitism relies on the ability of an organism to exploit its host. Trypanosoma brucei is a unicellular parasite responsible for a fatal disease in humans (sleeping sickness), and for a chronic disease in cattle (nagana) in Sub-Saharan Africa. We are interested in understanding the cellular and molecular mechanisms employed by T. brucei to be an effective parasite.
• Miguel Prudêncio Lab - Our lab's research interests span a wide range of topics within the malaria field, with particular emphasis on the hepatic stage of infection. We are interested in elucidating hitherto obscure aspects of the biology of Plasmodium infection, unveiling novel host-parasite interactions, and developing new drug- and vaccine-based anti-malarial strategies.
• Visit to facilities: Insectaries / P. falciparum and bioimaging.
Site Visit 5 • Coimbra Hospital and University Centre (CHUC) and University of Coimbra (UC) - Health Science Campus
by registration only
Bus departing from Calouste Gulbenkian Foundation
• Coimbra Hospital and University Centre (Infectious Diseases Department and Clinical Research Unit);
• Research centres in Biomedical and Life Scieces based at the University of Coimbra: CNC - Center for Neuroscience and Cell Biology) and IBILI - Institute for Biomedical Imaging and Life Sciences (Faculty of Medicine of the University of Coimbra).
More information:
Coimbra Health
Consortium formed by University of Coimbra (UC) and Coimbra Hospital and University Centre (CHUC)
Coimbra Hospital and University Centre (CHUC)
Coimbra Hospital and Universitary Centre (CHUC) mission is to deliver high-quality clinical care in a context of pre and postgraduate training with a strong focus on research, scientific knowledge and innovation. CHUC´s excellence centres ensure high standard healthcare services being the Portuguese hospital with the largest number of Centers of Reference and belonging to ten Europe Reference Networks.
iCBR, Coimbra Institute for Clinical and Biomedical Research (CNC.IBILI/CIBB)
Established in 2013, CNC.IBILI Consortium at University of Coimbra (UC) integrates the Centre for Neuroscience and Cell Biology (CNC) and the Institute for Biomedical Imaging and Life Sciences (IBILI). CNC.IBILI was recently renamed as CIBB (Centre for Innovative Biomedicine and Biotechnology) and integrates CNC and iCBR (Coimbra Institute for Clinical and Biomedical Research; former IBILI). CNC.IBILI/CIBB is the result of a continuous and ongoing effort to bring together in a single hub of excellence researchers in Biomedicine and Biotechnology. It is a leading top-ranking research institute in Life & Health Sciences, graded Excellent in all FCT evaluations, with strong international recognition in several research areas. CNC.IBILI/CIBB, a UC flagship in biomedical sciences, hosts researchers from the faculties of Medicine, Pharmacy, Sciences and Economics, from Coimbra University Hospitals (CHUC) and Healthcare system and key collaborators from biotech and pharmaceutical industry. CNC.IBILI/CIBB currently has over 580 members including integrated PhD holders (350) and supporting technicians/officers (ca. 60). Committed to fundamental and translational research and advanced training it has three strategic research lines: Neuroscience & Disease; Metabolism, Ageing & Disease, and Innovative Therapies. CIBB is competitive in obtaining (inter)national research funding and uniquely positioned in translating fundamental research into clinical and/or marketable applications. CIBB’s activities are supported by world-class core facilities/infrastructures, including (a) the microscopy Units; (b) a cutting-edge medical imaging centre (ICNAS) with MRI, PET and a cyclotron for tracer synthesis; (c) state-of-the-art high-throughput screening platform; (d) Mass Spectrometry, Flow Cytometry, and Next-Generation Sequencing Units. (e) Imaging and electrophysiology for vision research; (f) Animal Facilities.
CNC - Center for Neuroscience and Cell Biology
The Center for Neuroscience and Cell Biology (CNC) is a nonprofit research institute founded in 1990, aiming to foster biomedical research and multidisciplinary graduate teaching at the University of Coimbra. CNC was the first established “Laboratório Associado” in Portugal, and it has steadily increased the scope of scientific competences over the years, with a strong focus on the exploitation of the fundamental mechanisms of aging and brain diseases.
Updated on
18/10/2018 16:59:18
|